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PSF : "relative probability" of forming stones  
Pth : Parathyroid  
Rln  : recurrent laryngeal nerve 
SD  : standard deviation 
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TRPV5 : transient receptor potential vanilloid 5 
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ABSTRACT  
TITLE 
Comparative  study  to assess the relationship between renal calculi, thyroid and 
parathyroid hormones and urinary infections at tertiary care centre 
INTRODUCTION 
Kidney calculi is a common problem seen in people and lot of situation is seen where 
people having a calculus is also suffering from UTI. Since the stones are common 
calcium,phosphorus and oxalate, this study is to find any relationship between them 
AIMS AND OBJECTIVES 
 To study  the  relation between  thyroid and parathyroid involvement in patients 
with renal calculi 
 To study the relation between urinary tract infection and renal calculi 
 To study the effect of selected ions with respect to renal calculi in patients 
METHODOLOGY  
In this study we had a group of 46 patients, all having renal calculi and some suffering 
from UTI, some having altered thyroid and parathyroid levels. 
RESULT  
The incidence of stone formers are seen mostly in the age bracket of 40-49 
years, most commonly found in males than females. We found a strong association 
between UTI and Renal stones, in which 58.7% suffering from renal calculi had UTI 
in our study. Among all the studies of urine culture, E.Coli was the most predominant 
organism (45.7%) associated with stones. Ca-Oxalate predominated our study but 
there was limited inter-relationship between Serum Calcium, Urine Calcium, Urine 
Phosphate and TSH. 
 
CONCLUSION 
Over all our study showed significant and positive results based on various 
aspects of Renal calculi and UTI, Thyroid, Parathyroid hormones. We have a positive 
association between renal calculi and Uti but successful establishment of relationship 
between thyroid and parathyroid hormones could not be elicited as the total number of 
cases were only limited. 
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INTRODUCTION 
Urolithiasis is the commonest afflictions in the present world. Once majorly 
seen in men is now gender blind. There has been revolutionary progress in leaps and 
bounds towards the management of renal stones, but surgery only succeeds in 
removal of the stone but don't change the pattern of the disease. The gross annual 
Shell out with insurance claims relating to the diagnosis of renal calculi amounts to a 
staggering $2.1 billion in 2000 which was a 50% hike from 1994. (1) 
 
Fig 1: LOCATION OF THE PAIN of renal calculi (light red) and ureteric calculi 
(red) 
These renal calculi recur very frequently and in order to curb the formation of 
these stones we need a proper study to understand the etiology, epidemiology, 
pathogenesis of the renal calculi and carry out programs which will help us to reduce the 
incidence and recurrence of the stone formation. It is suggested that the increase in the 
incidence of renal calculi worldwide attributes to the fact that there is rise in detection of 
asymptomatic calculi through increase utilisation of radiographic imaging, particularly 
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computerised tomography (2,3).  
There is also a racial/Ethnic difference noted in the incidence of stone 
formation, renal stones primarily affected the whites in United States of America., 
followed by Hispanics (73%), Asians (63%), African -Americans (44%). (4) 
Geography too plays a role in the formation of stone, it though follow 
environmental risk factors and higher preponderance is seen in warm or dry climates 
such as hills, deserts, hot areas. Climate too plays an upper hand in stone formation, 
as seasonal variations in stone formation is related to temperature by way of losses of 
fluid by sweat and increases in Vitamin D due to sunlight(5). It is noted that stone 
formation more in June through September with peak of about 1-2 months of highest 
mean temperature.(6) 
Urolithiasis is a serious health problem due to its high expenditure, high 
morbidity, and resulting in end stage renal disease.(7)  
 UTI is one of the most common bacterial infection occurring invariably in all 
age groups, and 20% of women on an average are also affected by it at some point in 
their life. Urinary calculi rank third behind UTI and pathogenic conditions of the 
prostate. (8) Antibiotic treatment in both primary and secondary care if given for any 
disease urinary tract infection ranks 2nd in it. It is also most common hospital 
acquired infection.(9) 
In recent studies an article stated that the percentage of people coming in with 
kidney stones has risen from around 15% of all patients to nearly 70%. Also men are 
around 2-3 times more at risk than women. But in recent studies its found out that the 
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incidence is on a high in women. (10) 
Stone disorders are more common in men than in women. Majority of the 
patients are between the 20-55 years of age. The highest incidence of kidney stones is 
in 30-45 years of age group and the incidence declines after the age of 50 years. 50% 
have recurrence of kidney stones.(11) 
Many factors are involve in the incidence and the type of stones formation 
which include metabolic changes, diet, climatic changes, lifestyles, occupation, 
urinary stasis and urinary tract infections, long term indwelling catheters and 
neurogenic bladder. Nutritional and environmental factors may themselves cause 
urinary stones formation or exaggerate the metabolic risk factors of the renal calculi. 
Strenuous physical exercise excessive sweating may predispose to stone 
formation by urinary concentration, altered urinary pH and reducing the urinary 
citrate level. (12) 
The possible indicators of the renal calculi include the dull aching pain in the 
back, acute colic which is a classical pain described as pain from the loin to the groin, 
accompanied by nausea, vomiting and gaseous distension, urinary tract infections, 
increased frequency of urine, pain of burning while passing urine and passage of 
blood in the urine.(13) 
Hyperthyroid may result in forming kidney stones. Hyperthyroid results in 
hypercalcemia among one fifth of the patients having normal, mildly elevated or 
excess serum calcium due to high bone turn over. Hyperthyroidism can be a cause for 
renal stones by distal renal tubular acidosis.(14) 
Introduction 
 
  4 
 
Calcium and phosphorus concentration in the extracellular fluid is regulated 
by Parathyroid hormone.(14) Over activity of parathyroid glands can lend a hand in 
formation of kidney stones.  
Kidney stones are generally calcium phosphate or calcium oxalate. Increased 
phosphate excretion in urine is due to hypercalciuria. This hypercalcemia is secondary 
to Hyperparathyroidism.(15) Hyperparathyroidism can cause kidney stones that may 
lead to bladder outlet obstruction, infection and renal damage. 
Renal calculi is a multifactorial disease with several underlying disorders of 
metabolism. That is why diet is an important treatment, especially in the prevention of 
recurrences. Nutritional intervention is based on a high water intake, physiological 
calcium intake and animal protein restriction and vitamin C intake <2gm daily. In 
case of diagnosed disorders of specific metabolic pathways, a low oxalate, low 
Purine-diet should be advisable.(16) 
We have an increased number of patients visiting with problems of 
urolithiasis, hence this study is being carried out to establish relationship between 
renal calculi and thyroid and parathyroid glands along with coincidence of UTI in the 
southern most region of India Kulasekharam, Kanyakumari. Recently however with 
the utilisation of the advanced endoscopic techniques, renal stone management has 
become a minimal invasive treatment. Strategy of the renal stone management 
depends on the stone location, the age of the patient, the environmental factors, the 
physical situation like the obesity, bleeding disorders and the anatomical conditions 
like the ectopic kidney. 
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Fig 2: Deaths due to urolithiasis - Demographic Data. 
According to world health organisation, estimated deaths from complications 
arising from renal calculi India stands among one among of the few countries to be 
vastly affected. So we know how difficult it is to ignore the incidence and 
complication arising from urolithiasis. 
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AIMS AND OBJECTIVES 
 To study the relation between thyroid and parathyroid involvement in patients 
with renal calculi 
 To study the relation between urinary tract infection and renal calculi 
 To study the effect of selected ions with respect to renal calculi in patients 
Alternative Hypothesis and Scientific justification of the study 
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ALTERNATIVE HYPOTHESIS 
Surgical treatment provides symptomatic relief and significant improvements 
for renal calculi compared to medical conservative treatment 
SCIENTIFIC JUSTIFICATION OF THE STUDY 
Most of the studies based on renal calculi have been carried out mostly on 
causes and type of stones with recurrence. As of now, surgical treatment of renal 
calculi is common, but there is limited studies based on the interrelationship between 
urolithiasis, thyroid and parathyroid hormones and UTI remains uncertain. Very few 
studies have been conducted in India especially South India. So I intend to assess the 
relationship between kidney stones, thyroid and parathyroid hormones and UTI and 
preventing patient to undergo surgery and the complications pertaining to it, and also 
in understanding the risk factors leading to renal calculi. 
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REVIEW OF LITERATURE 
KIDNEYS 
LOCATION  
The paired ovoid kidneys are located on either side of the vertebral column in 
the retroperitoneal connective tissue of the posterior abdominal wall. The kidneys lie 
on the Psoas muscle, thus the long axis of the kidneys are oblique with upper poles 
more posteromedial than lower poles. 
The right kidney is situated little lower than the left kidney due to the 
displacement by the liver, hence it sits around 1-2cm lower than the left kidney. The 
right kidney occupies L1-L3 whereas the left kidney occupies space between T12-L3. 
ANATOMY 
Each kidney measures about : 
10-12 cm in length,  
5 - 7.5 cm in width,  
2.5 - 3.0 cm in thickness.  
Weight of the kidney 125-175gm in males, 10-15gm less in females. 
Structures anterior to the right kidney are suprarenal glands, the liver, second 
part of duodenum, right colic flexure and small intestine. 
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• Structures posterior to the right kidney are- the diaphragm 
 the costo- diaphgrammatic recess 
 the 12th rib 
 the poses major muscle 
 the quadrates lumbar muscle 
 transverse abdominis muscle 
 ilio-inguinal nerves. 
• Structures anterior to the left kidney are - suprarenal glands 
 stomach 
 tail of pancreas  
 left colic flexure  
 small intestine.(17) 
.
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Fig 3 : Shows anterior relations of right and left kidney 
 
Fig 4 : Shows the organization of the fat and fascia surrounding the kidneys 
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Fig 5: Shows the posterior relationship of the kidney. 
Structures posterior to the left kidney are same as right kidney with addition of 
11th rib due to higher position. 
Fascias covering the kidneys : 
a. Enclosing the renal parenchyma is the fibrous tissue called as renal capsule, it is 
lightly bound.  
b. Immediately adjacent to it is the perinephric layer of fat, this layer covers the 
kidney and the ureter and is called as the adipose capsule.  
c. Continuing outward is a membranous condensation of extra peritoneal 
connective tissue called as the Gerota's fascia.  
d. Outside to it is the paranephric layer of fat. 
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STRUCTURE  
 The renal parenchyma consists of an outer cortex and an inner medulla. The 
cortex is an outer, pale, continuous broadband of tissue. It is a dense homogenous 
tissue consists of renal corpuscles and convoluted part of renal tubules.  
 The medulla is an inner layer of discontinuous tissue caused by the inward 
projection of the cortical tissue called renal columns. The medulla is darker brown 
than the cortex and is composed of the renal pyramids.  
 Each pyramid contains the descending and ascending limbs of the renal 
tubules and the collecting tubules. The apex of each pyramid is called a renal papilla, 
and it projects into a minor calyx. The medial margin of each kidney is occupied by 
the hilum.  
 The hilum expands into a central cavity called the renal sinus and is the site 
of entrance or exit for blood vessels, lymphatics, and nerves.  
 It transmits from anterior to posterior. The renal vein, the anterior branch of 
the renal artery, the ureter. And the posterior branch of the renal artery. It also 
contains fat and the renal pelvis.(18) 
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Fig 6 : Internal structure of Kidney 
 
Fig 7: Segmental circulation of the Renal vessels 
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BLOOD SUPPLY 
 The kidneys are supplied by the renal arteries, which arise from the lateral 
aspect of the aorta just inferior to the origin of the superior mesenteric artery (usually 
between L-1 and L-2) .  
 As each renal artery approaches the renal pelvis, it divides into anterior and 
posterior branches that pass on either side of the renal pelvis and major calyces.  
 
Fig 8 : Branches of Renal Artery 
VENOUS DRAINAGE 
 The venous drainage of the kidneys consists of anastomosing channels 
forming a single renal vein that exits at the hilum. Most tributaries of the renal vein 
pass anterior to the renal pelvis but on occasion one may pass posterior to this 
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structure. After exiting the hilum. The left renal vein passes anterior to the aorta and 
posterior to the superior mesenteric artery as it approaches the inferior vena cava. The 
right renal vein has a short direct path to the inferior vena cava and enters this vessel 
at approximately the same level as the left renal vein.  
 
Fig 9 : Venous Drainage of Kidney with collaterals 
LYMPHATICS 
 The lymphatic drainage of each kidney is to the lateral aortic or lumbar nodes 
around the origin of the renal artery.  
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NERVE SUPPLY 
 Sympathetic pre ganglionic nerves originate from the T8-L1 spinal segments, 
with contributions mainly from the celiac plexus and a lesser contribution from the 
greater splanchnic, intermesenteric, and superior hypogastric plexuses.  
 Post ganglionic sympathetic nerve fibre travel to the kidney via the autonomic 
plexus surrounding the renal artery. 
 Parasympathetic fibres from the vagus nerve travel with the sympathetic 
fibres to the autonomic plexus along the renal artery. The renal sympathetics cause 
vasoconstriction, and the parasympathetics cause vasodilatation.(19) 
URETERS 
 The ureters are muscular tubes that extend ~25 cm from the kidneys to the 
posterior surface of the bladder . Each ureter has an upper expanded end called the 
renal pelvis. Of clinical relevance is the fact that three constrictions are present as the 
ureter descends from the kidney to the bladder. These constrictions occur at the 
ureteropelvic junction, where the ureter crosses the pelvic brim and where the ureter 
enters the bladder wall. In addition. obstruction of the ureter maybe caused by 
stenosis of the uretero- pelvic junction. (20) 
PHYSIO- CHEMISTRY AND PATHOGENESIS OF STONE FORMATION 
 The process of calculus formation involves a complex cascade of events that 
prevail as the glomerular filtrate via the nephron. It starts with supersaturated urine 
that results into stone-forming salts so as to dissolved ions or molecules expedite out 
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of solution forming crystals or nuclei.  
Once established, crystals ultimately form stones by being retained in the 
kidney at anchoring sites that favours growth and aggregation, or may pass out via 
urine.(21) 
 
Fig 10 : Stages of Stone Formation 
Pathogenesis of Stone Formation: 
I. State of saturation 
II. Nucleation and Crystal Growth, Aggregation, and Retention  
III. Inhibitors and Promoters of Crystal Formation  
IV. Matrix 
 
Review of Literature 
 
  18 
 
STATE OF SATURATION 
 A concentration product describes a solution containing ions or molecules of 
a sparingly soluble salt. Once an aqueous solution of a salt attains a point where no 
more added salt crystals dissolve, it is considered to be saturated.  
 The point where the dissolved and crystalline components are present in 
equilibrium for a particular set of conditions is called the thermodynamic solubility 
product (Ksp),. Any further addition of crystals at Ksp to the saturated solution will 
lead the crystals to precipitate unless the state of the solution, such as pH or 
temperature, are varied.  
 Usually, in urine, inspite of the presence of high amount of stone-forming salt 
components like calcium oxalate that exceed the solubility product, crystallization 
does not necessarily occur due to the presence of inhibitors and other molecules 
which permits higher amount of calcium oxalate to be held in solution before 
precipitation or crystallization occurs.  
 However, crystal formation can be present even in this stage under certain 
conditions. Nucleation occurs in part of nephron, when the local concentration 
products exceed the formation product for enough period of time.  
 Second, increased urine transit time due to local areas of obstruction or stasis 
in the upper urinary tract leads to crystal formation to occur in the metastable urine. 
Finally, microscopic impurities and other components in the urine can ease the 
nucleation process by adhesion of the crystal components in a geometric fashion that 
is similar to the native crystal. The crystals are then formed at a point where no longer 
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the salt can be held in solution . 
The solubility product and the formation product determines the three major 
states of saturation in urine: undersaturated, metastable, and unstable.  
Nucleation and Crystal Growth, Aggregation, and Retention  
In normal human urine, the amount of calcium oxalate is 4x higher than its 
solubility in water. Urinary determinants favouring stone formation are low volume 
and citrate concentration, while raised calcium, oxalate, phosphate, and uric acid all 
accentuate the calcium oxalate supersaturation. Crystallization occurs once the 
concentration product of calcium oxalate exceeds the solubility product. However, the 
presence of urinary inhibitors and other substances, cut down the rate of calcium 
oxalate precipitation as it occurs only when supersaturation surpasses the solubility by 
7 to 11 times.  
 The earliest crystal structures that does not dissolve are nuclei. In case of 
small unstable nuclei; below a critical size threshold, breaking up of the crystal is 
favoured over crystal formation.  
 The nuclei will persist either if the supersaturation level and stability of nuclei 
are adequate or the time to nucleation is short when compared to the transit time of 
urine through nephron. The promoters by providing a surface with a binding site that 
conciliates the crystal structure of the nucleus, stabilize nuclei whereas the inhibitors 
like citrate ,destabilize the nuclei.  
 In urine, adsorption of crystal nuclei onto existing surfaces of epithelial cells 
(22) through heterogeneous nucleation, or other crystals (23) , cell debris (24). 
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The aggregation of the crystals will occur if the nuclei forms and grows, 
leading to formation of larger particles within minutes that can conceal the tubular 
lumen.  
 The process of crystal formation or aggregation can be prevented by 
inhibitors. Magnesium and citrate inhibit crystal aggregation. The calcium oxalate 
nucleation, aggregation and growth will be inhibited by an acidic glycoprotein, 
Nephrocalcin, made in the kidney.(25,26) 
 Tamm-Horsfall mucoprotein which supercedes other proteins, inhibits 
aggregation (27), and uropontin inhibits crystal growth(28). The light chain of inter-α-
trypsin, Bikunin has been shown to be a good inhibitor of crystal nucleation and 
aggregation.  
 Based on these findings, large number of investigators has revised the role of 
Randall plaques in the pathogenesis of stone formation.  
 Mapping by the papillae of patients who have undergone endoscopic stone 
removal, and also control subjects who have undergone endoscopy for various other 
reasons, resulted in the finding that papillary plaques happened in 74% of stone 
formers when compared with only 43% of the control subjects. (29) 
 It has been hypothesized by(30) that the triggering event which results in the 
development of stones could be a vascular injury to the vasa recta situated close to the 
renal papilla.  
 An atherosclerotic-like reaction could occur after repair of damaged vessel 
walls that can result in the calcification of the endothelial wall, and hence is followed 
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by extension into the papillary interstitium by erosion and further into the collecting 
ducts, in which it can act as a site for the formation of stone.  
 
  Fig 11: A. Endoscopic    B. Histologic 
A. Images of Randall plaques in calcium oxalate patients. Sites of randall plaques ( 
arrows) appear as irregular white areas beneath the urothelium. B low magnification 
light- microscopic image of papillary biopsy specimen. Sites of calcium deposits were 
stained black by the Yassue metal substitution method for calcium histochemistry  
A different view of the pathogenesis of stone formation was presented (31) 
based on extensive analysis of papillary plaques which were derived from biopsies 
collected during percutaneous nephrolithotomy in idiopathic calcium oxalate stone 
formers.  
 The origin of the plaque was localised to the basement membrane of the thin 
limbs of the loops of Henle and it was shown that the plaque continues to extend 
through the medullary interstitium to a sub epithelial site.  
 As the plaque continues to erode through the urothelium, it is found to form a 
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stable, anchored surface on which calcium oxalate crystals can nucleate and further 
grow as anchored stones.  
 In idiopathic calcium oxalate stone formers, the amount of papillary surface 
which is covered by plaque was found to correlate negatively with the urine volume 
whereas positively with hypercalciuria (32,33) and the number of stones formed (34). 
This further collaborates the clinical evidence for the sequence of events. (35)  
It is observed that in almost half of a studied cohort of calcium oxalate stone 
formers the stones were found to be attached to the renal papillae proposing that 
formation of attached stones is an initial step in the sequence of events of stone 
formation.  
 Retention of crystals in the tubular lumen may lead to nephrocalcinosis, 
which may or may not be associated with renal stone formation. 
Inhibitors and Promoters of Crystal Formation  
 At the concentrations at which most stone-forming salt components including 
calcium, oxalate, and phosphate are present in urine, urine is supersaturated, thereby 
favoring crystal formation.  
 However, the presence of substances that raise the level of supersaturation 
needed to start crystal nucleation or decrease the rate of crystal formation or 
aggregation prevents the stone from forming on a regular basis.  
 Citrate by various ways inhibits the formation of calcium oxalate and calcium 
phosphate stones. It forms a complex with calcium first, and hence reduces the 
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availability of ionic calcium left to interact with oxalate or phosphate.(36,37)  
 Second, it is found to directly inhibit the spontaneous precipitation of calcium 
oxalate (38) and also prevents the calcium oxalate crystals from agglomerating (39). 
Though it has a very small inhibitory effect on calcium oxalate crystal growth, it has 
significant activity in decreasing the calcium phosphate crystal growth (36).  
 Finally, citrate prevents the heterogeneous nucleation of calcium oxalate by 
monosodium urate (40).  
 The complexation of magnesium with oxalate, confers it’s inhibitory activity 
which further decreases the ionic oxalate concentration and calcium oxalate 
supersaturation (36). 
 A recent study showed that magnesium pyrophosphate, phosphate, and 
magnesium have all been shown to inhibit crystal growth, but only high 
concentrations of magnesium and pyrophosphate have been shown to inhibit 
aggregation (41).  
 Two urinary glycoproteins namely nephrocalcin and Tamm-Horsfall 
glycoprotein, are powerful inhibitors of calcium oxalate monohydrate crystal 
aggregation (25). The acidic glycoprotein, Nephrocalcin, is contains mostly acidic 
amino acids that are produced in the proximal renal tubules and the thick ascending 
limb. In normal solution, this highly inhibits the growth of calcium oxalate 
monohydrate crystals (25). 
Tamm-Horsfall a surplus protein found in the urine is a powerful inhibitor of 
calcium oxalate monohydrate crystal aggregation, but not its growth.  
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Osteopontin is found to inhibit nucleation, growth, and aggregation of calcium 
oxalate crystals, and also to reduce the binding of crystals to renal epithelial cells in 
vitro (42,43). 
MATRIX 
 Renal calculi contains both crystalline and noncrystalline components. The 
noncrystalline component is termed as matrix, which usually accounts about 2.5% of 
the weight of the stone (44). In few cases, the matrix constitutes the majority of the 
stone (up to 65%), usually in relation to chronic urinary tract infection (44,45).  
MINERAL METABOLISM 
 CALCIUM 
 PHOSPHORUS 
 MAGNESIUM 
 OXALATE 
CALCIUM 
 About 30 to 40 % of dietary calcium is absorbed from the intestine, most of it 
in the small intestine and only about 10% of it is absorbed in the colon (46).  
 Vitamin D - dependent transcellular pathway which is saturable comprises the 
main pathway for intestinal calcium absorption when the intake of calcium is limited. 
This pathway is then downregulated by a diet rich in calcium (47,48).  
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 A very limited quantity of calcium is secreted into the lumen of the intestine, 
which reduces the net calcium absorption to such an extent that, overall, 100 to 300 
mg of a total average calcium intake of 600 to 1200 mg daily will be absorbed.  
 Calcium is always absorbed in the ionic state, and incomplete calcium 
absorption is for a certain extent due to the formation of soluble calcium complexes in 
the intestinal lumen. The substances which form a complex with calcium, such as 
phosphate, citrate, oxalate, sulfate, and fatty acids, decrease the availability of ionic 
calcium which is left for absorption (49).  
 Calcium easily complexes with the phosphate present in the intestinal lumen. 
Since calcium phosphate formation is dependent on pH (pK = 6.1), raised luminal pH 
increases the chance of calcium phosphate complexation, and hence reduces the 
availability of calcium.  
 Whereas calcium oxalate complex formation shows lesser pH dependence and 
complex formation and is less reversible.  Hence an oxalate-rich diet decreases 
calcium absorption, 
25(OH)2D3, the active form of vitamin D, is the most powerful stimulator of 
absorption of calcium from intenstine. Following the conversion of 7-
dehydrocholesterol in the skin to previtamin D3 which is favoured by sunlight, the 
previtamin D3 is hydroxylated in the liver to 25- hydroxyvitamin D3, which in turn is 
further hydroxylated in the proximal renal tubule to 1,25(OH)2D3. parathyroid 
hormone (PTH) and by hypophosphatemia trigger the conversion of 25-
hydroxyvitamin D3 to 1,25(OH)2D3. A decrease in serum calcium levels increases 
the secretion of PTH, which in turn stimulates 1α-hydroxylase, situated in the 
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mitochondria of the proximal renal tubule. Following transport through the 
bloodstream to the intestine, the 1,25(OH)2D3 binds to the vitamin D receptor 
situated in the brush border membrane epithelial cells in order to increase the 
absorption of calcium.  
Calcitriol exerts its action on the bone and kidney in addition to its action in 
promoting intestinal calcium absorption.1,25(OH)2D3, along with PTH, promotes the 
recruitment and differentiation of osteoclasts in bone that further removes calcium 
from the bone. Hence, the filtered load of calcium and phosphate raises. PTH is 
produced from the parathyroid gland, and the strongest stimulus for the secretion of 
PTH is decrease in serum calcium (50) PTH triggers active mobilization of calcium 
from bone by means of the action of osteoclasts, resulting in further raise in serum 
calcium and phosphorus.  
In kidney, PTH stimulates the renal calcium reabsorption and decreases the 
renal tubular reabsorption of phosphate. It also promotes the synthesis of 
1,25(OH)2D3, which results in increased intestinal calcium and phosphate absorption. 
However, PTH has no effect on the absorption of intestinal calcium.  
The paracellular absorption of calcium in the proximal tubule and thick 
ascending limb of the loop of Henle occurs by several mechanisms. First, calcium 
travels through paracellular channels found at the tight junctions of epithelial cells in 
the proximal tubule. Occludin, junctional adhesion molecules, and claudins constitute 
the integral membrane proteins of the tight junction (51),(52),(53) The Claudins group of 
proteins have four transmembrane domains (54),(53),  
Passive reabsortion of calcium from the lumen of the thick ascending limb of 
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the loop of Henle into the interstitial space is by a paracellular pathway initiated by a 
lumen-positive transepithelial voltage gradient (53). apical potassium secretion and 
basolateral chloride secretion, as well as by way of a transepithelial NaCl 
concentration gradient over the cation-selective paracellular channel in the thick 
ascending limb results in the positive luminal voltage. The CaSR has an important 
part the handling of calcium by kidneys, and the expression of which is mainly in the 
thick ascending limb. CaSR secretion is stimulated by serum calcium which raises the 
expression of claudin-14, which inturn blocks the calcium channels which are 
constituted by the claudin-16/19 complex. This reduces the paracellular calcium 
reabsorption (55),(56). calcium-sensing receptor (CaSR)  
Various mechanisms act to cause transcellular calcium absorption in the distal 
convoluted tubule (57,58). Calcium reaches the epithelial cells of the distal tubule via a 
transcellular channel (transient receptor potential vanilloid 5, or TRPV5), . This is 
different among other channels in the TRP family by means of its high calcium 
selectivity. The binding of calcium in the cell to a chaperone protein (calbindin-
D28k), facilitates its diffusion across the cell from the apical to the basolateral space 
from which it can then leave.  
PHOSPHORUS 
Both calcium and inorganic phosphate absorption are dependent on the 
saturable transcellular and nonsaturable paracellular transport. Saturable absorptive 
transport occurs at low phosphorus concentrations (1 to 3 mmol/L), Whereas at 
increased phosphorus levels, its absorption raises even without the saturation (59). 
Nearly 60% of dietary phosphate is absorbed in the intestine. A 1,25(OH)2D3- 
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regulated, sodium-dependent transport process is involved in the active absorption of 
phosphate from the intestine.(60,61) 
Phosphate absorption is dependent on the pH; It is reduced by low luminal pH 
and enhanced by high pH.  
PTH, inhibits renal tubular reabsorption of filtered phosphate and regulates 
renal phosphate handling.  
MAGNESIUM 
Absorption of magnesium from the intestine is by means of passive diffusion 
or active transport, even though passive diffusion accounts for most of the net 
magnesium absorption. Absorption ccurs in both the large and small intestine, with 
the majority from the distal small intestine.  
OXALATE  
Only 6% to 14% of ingested oxalate is absorbed. Thus it differs from Calcium 
metabolism (62,63),.Absorption happens throughout the intestinal tract, with nearly half 
or even more taking place in the small intestine and half in the colon(62).  
Hyperoxaluric stone formers absorb more oxalate as a response to an oral 
oxalate load when compared to stone formers who have normal oxalate excretion as 
suggested by recent studies. (64,65) 
Transport of oxalate occurs through transcellular as well as paracellular 
pathways. Transport through paracellular pathways and some nonmediated 
transcellular pathways is mainly passive, being driven by electrochemical or 
concentration gradients, but still the transcellular transport is mainly carried out by 
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membrane carriers. The transport protein which is responsible for oxalate secretion is 
thought to belong to the SLC26 family of solute-linked carrier (SLC) anion 
exchangers.  
There is evidence to the fact that oxalate might be secreted and also absorbed, 
in the intestine (66).  
Oxalate absorption is also influenced by the presence of oxalate binding 
cations including calcium or magnesium and also oxalate-degrading bacteria. Calcium 
oxalate complexes results from the congestion of foods rich in calcium- and oxalate. 
This limits the amount free oxalate ion available for absorption(67,68,69).  
Almost all of absorbed oxalate is totally excreted in the urine (70,71). 
Endogenous production in the liver (from ascorbic acid and glycine) and dietary 
sources contribute to urinary oxalate. On average, nearly half of urinary oxalate is 
derived from the diet, with the exact amount determined by the relative amount of 
ingested calcium and oxalate (72).  
PATHOPHYSIOLOGY OF UPPER URINARY TRACT CALCULI  
 
Fig 12 : Stone composition and relative occurrence 
Review of Literature 
 
  30 
 
Classification of Nephrolithiasis  
Calcium is the main component of almost 80% of stones. Calcium oxalate 
comprises nearly 60% of all stones; whereas mixed calcium oxalate and 
hydroxyapatite constitute 20% and brushite stones contribute to 2%. Uric acid and 
struvite (magnesium ammonium phosphate) constitute about 7% of stones, whereas 
cystine stones represent only about 1% (73).  
Uric acid, cystine, and struvite stones are form in comparatively different 
settings; uric acid stones form only in acidic urine, cystine stones occur due to 
impaired renal reabsorption of cystine, and stones due to infection occur in alkaline 
urine which produced by urease- producing bacteria. For some stones like cystine 
stones, it is important to know about the chemical composition of the stone which 
might provide enough information to trigger correct therapy. As various etiologies are 
associated with calcium-based stones, it is important to know about the underlying 
metabolic disorders and environmental factors that which predispose to stone 
formation  
Calcium Stones  
Hypercalciuria  
Calcium stone formers are found to have hypercalciuria more 
commonly.(37)(74)(75).  
Lastly, recent investigations of Randall plaques as potential precursors to 
calcium stone formation have shown that plaques occur more commonly in stone 
formers and their number directly correlates with urine calcium levels and number of 
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stone episodes (33)(34) 
High urinary calcium concentrations lead to increased urinary saturation of 
calcium salts (76) and reduced urinary inhibitory activity by way of complexation with 
negatively charged inhibitors such as citrate and chondroitin sulfate (77). Normally 
renal filtration is of about 270 mmol of calcium daily and out of which only 4 mmol is 
reabsorbed(78). However, a variety of conditions lead to elevated urinary calcium 
levels and increased urinary saturation of calcium salts. Criteria which defines 
hypercalciuria do vary, present definition states values higher than 200 mg of urinary 
calcium/day after adherence to 100-mg sodium diet for 1 week, and 400-mg calcium 
as hypercalcicuria (79). (78) Hypercalciuria is defined as the elimination of higher than 4 
mg/kg/day or higher than 7 mmol/day in men and 6 mmol/day in women.  
Historically, the term idiopathic hypercalciuria was applied to stone formers 
for whom classification of their metabolic abnormality was difficult. Calcium 
transport is regulated at three sites: intestine, bone, and kidney. Dysregulation at any 
of these sites can lead to hypercalciuria. hypercalciuria is into three basic subtypes 
classified on the pathophysiologic abnormalities:, renal hypercalciuria due to primary 
renal leak of calcium, absorptive hypercalciuria due to increased absorption of 
calcium from intestine and resorptive hypercalciuria due to elevated bone 
demineralization.  
Absorptive Hypercalciuria.  
Absorptive hypercalciuria (AH) is defined as high urinary calcium excretion 
(>0.2 mg/mg creatinine) after an oral calcium intake. Although fasting urinary 
calcium is usually normal in AH (<0.11 mg/dL glomerular filtration), severe forms of 
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AH may occasionally be associated with fasting hypercalciuria as well. The 
underlying pathophysiologic abnormality in AH is increased intestinal absorption of 
calcium, which occurs in approximately 30% of stone formers. Dietary calcium 
restriction may normalize urinary calcium in some patients with AH (type II) but not 
in others (type I). The add-on systemic load of calcium due hyperabsorption of 
calcium in the intestine results in a transient elevation in serum calcium, which 
repress serum PTH and leads to increased filtration of calcium in the kidney, finally 
resulting in hypercalciuria. Because the increase in intestinal absorption of calcium is 
matched by enhanced renal calcium excretion, serum calcium level remains normal.  
The cause of increased intestinal absorption of calcium has been variously 
ascribed to vitamin D–independent and dependent processes, as well as to 
upregulation of the vitamin D receptor (80).  
Hypersensitivity to vitamin D has also been shown to increase intestinal 
calcium absorption and cause hypercalciuria (75).  
Another proposed etiology of AH is renal phosphate wasting leading to a 
subsequent increase in active vitamin D. Patients with hereditary hypophosphatemic 
rickets with hypercalciuria (HHRH) manifest this abnormality, which is characterized 
by decreased renal reabsorption of phosphate, hypophosphatemia, and a subsequent 
compensatory increase in vitamin D levels, leading to enhanced absorption of calcium 
and phosphate from the intestine and hypercalciuria (81).  
Renal Hypercalciuria. The kidney filters approximately 270 mmol of calcium 
and must reabsorb more than 98% of it to maintain calcium homeostasis (75). 
Approximately 70% of calcium reabsorption occurs in the proximal tubule, with 
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paracellular pathways predominating (82). In hypercalciuria of kidneys, there is 
impairment of renal tubular reabsorption of calcium leading to increased urinary 
calcium levels causing secondary hyperparathyroidism (83). Serum calcium levels 
remain normal because the renal loss of calcium is compensated by enhanced 
intestinal absorption of calcium and bone resorption as a result of increased secretion 
of PTH and enhanced synthesis of 1,25(OH)2D3. Normal serum calcium but elevated 
fasting urinary calcium levels (>0.11 mg/dL glomerular filtration) values are features 
of renal hypercalciuria. The elevated fasting urinary calcium and serum PTH levels 
differentiate renal from absorptive hypercalciuria.  
Dent disease (X-linked recessive nephrolithiasis) is related to defects in 
chloride channel-5 (ClC-5), located in the α-type intercalated cells of the collecting 
ducts, the thick ascending limb of the loop of Henle and the the proximal renal tubule. 
Dent disease is characterized by proteinuria, hypercalciuria, nephrolithiasis, 
nephrocalcinosis, and progressive renal failure.  
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) 
is caused by mutations in claudin-16 (also known as paracellin-1) and claudin-19, 
members of the claudin gene family of tight junction proteins that are involved in the 
voltage- driven paracellular reabsorption of magnesium and calcium in the thick 
ascending limb and distal convoluted tubule (84,85) 
Resorptive Hypercalciuria.  
Resorptive hypercalciuria is an uncommon abnormality commonly associated 
with primary hyperparathyroidism. Primary hyperparathyroidism is a result of 
nephrolithiasis in about 5% of cases (86). Excessive secretion of PTH from parathyroid 
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adenoma causes excessive bone resorption and elevated renal synthesis of 
1,25(OH)2D3, which in turn enhances intestinal calcium absorption. The net effect is 
elevation of calcium levels(urine & serum) and fall in serum phosphorus levels.  
Primary hyperparathyroidism is associated with nephrolithiasis in less than 5% 
of affected individuals (87,88). However, the diagnosis should be suspected in patients 
with kidney stones and serum calcium levels higher than 10.1 mg/ dL(89),(79).  
PTH also increases excretion of bicarbonate and phosphorus from the 
proximal renal tubule, resulting in phosphaturia and mild hyperchloremic acidosis. 
Sarcoid and Granulomatous Disease. A, infrequent causes of resorptive 
hypercalciuria include hypercalcemia of malignancy, sarcoidosis, thyrotoxicosis, and 
vitamin D toxicity. Many granulomatous diseases, like leprosy, tuberculosis, silicosis, 
histoplasmosis and sarcoidosis are known to cause hypercalcemia. Out of these, 
kidney are most commonly related in cases of sarcoidosis. The hypercalcemia in 
sarcoidosis is related to the production of 1,25(OH)2D3 from 1α-hydroxylase seen in 
macrophages of the sarcoid granuloma, causing high absorption of calcium from the 
intestine, hypercalciuria & hypercalcemia (90);(91).  
Pulmonary alveolar cells and lymph node homogenates in patients with 
sarcoidosis are capable of synthesizing vitamin D, a function usually limited to the 
kidney. Most patients with sarcoidosis have a suppressed level of PTH secondary to 
hypercalcemia (92). Sarcoidosis can be individualised from other diagnoses with 
initiation of corticosteroid therapy which results through rapid resolution of 
hypercalcemia(93).  
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Malignancy-Associated Hypercalcemia. While primary hyperparathyroidism 
is the most common cause of hypercalcemia in an outpatient setting, malignancy is 
the main cause of hypercal- cemia in hospitalized patients (94).  
Glucocorticoid-Induced Hypercalcemia. Glucocorticoids alter calcium 
metabolism significantly by their effect on the intestine, bone, and parathyroid glands. 
Glucocoritcoid results in osteopenia with chronic use by promoting bone resorption 
and lowering bone formation hence they alter the calcium metatbolism in bones(95).  
Hyperoxaluria  
Hyperoxaluria, is defined as urinary oxalate greater than 40 mg/day, leading to 
increased calcium oxalate saturation in the urine and subsequent formation of calcium 
oxalate stones. Additionally, due to renal tubular cell injury mediated by lipid 
peroxidation and the generation  of oxygen free radicals oxalate has been seen in 
growth and retention of crystals (96).  
Causes of hyperoxaluria include any abnormality in the biosynthetic pathways 
(primary hyperoxaluria); malabsorptive states of the intestine associated with 
inflammatory bowel disease, celiac sprue, or intestinal resection (enteric 
hyperoxaluria); and excessive dietary intake or high substrate levels (vitamin C) 
(dietary hyperoxaluria).  
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Fig 13: Pathway of oxalate metabolism in the liver 
Primary Hyperoxaluria.  
The primary hyperoxalurias (PHs) are the result of rare autosomal recessive 
inherited disorders in glyoxylate metabolism by which the normal conversion of 
glyoxylate to glycine is prevented, leading to preferential oxidative conversion of 
glyoxylate to oxalate, an end product of metabolism. 
The markedly high levels of urinary oxalate that ensue (<100 mg/day) lead to 
elevated calcium oxalate saturation with calcium oxalate complex and crystals 
formation in the renal tubular lumen. 
Some crystals attach to the surface of renal tubular epithelial cells and further 
aggregate into stones, whereas others are internalized into tubular cells and then 
extruded into the renal interstitium, leading to marked nephrocalcinosis (97). Renal 
injury may be a consequence of direct cell toxicity from either high oxalate 
concentration or calcium oxalate crystals, mediated through reactive oxygen species. 
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Renal impairment occurs from recurrent obstructing calcium oxalate stones and as a 
result of renal parenchymal inflammation and interstitial fibrosis from severe 
nephrocalcinosis (98). With progressive renal damage, renal elimination of oxalate is 
impaired, leading to systemic deposition of calcium oxalate crystals, or systemic 
oxalosis.  
The primary enzyme catalyzing glyoxylate conversion to glycine is the 
pyridoxal phosphate–dependent alanine-glyoxylate aminotransferase (AGT), which is 
synthesized in the liver peroxisome. Mutations in this gene (AGXT) result in primary 
hyperoxaluria type 1 (PH1), and patients with this disorder have elevated levels of 
oxalate and frequently glycolate. End-stage renal disease (ESRD) occurs during the 
second to third decade of life in most patients with PH1, making it the most 
aggressive form of the disease (97).  
Primary hyperoxaluria type 2 (PH2) is associated with a defect in glyoxylate 
reductase/hydroxypyruvate reductase (GRHPR) in the liver, resulting in hyperoxaluric 
nephrolithiasis, but with a less hostile route in relation to renal failure than PH1(99). 
Patients with PH2 have elevated urinary levels of L-glyceric acid and oxalate because 
reduced GRHPR enzyme activity leads to increased hydroxypyruvate and glyoxylate, 
which are converted by lactate dehydrogenase to L-glyceric acid and oxalate, 
respectively. A total of 30 mutations have been identified in the GRHPR gene (100).  
A third type of primary hyperoxaluria is the latest type of addition. Primary 
hyperoxaluria type 3 (PH3) is due to a faulty mitochondrial enzyme, 4-hydroxy-2-
oxoglutarate aldolase (HOGA), which might have a part in hydroxyproline 
metabolism (101).  
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If untreated, PH1 causes end-stage renal failure, by age 15 in approximately in 
half of the affected patients and is related with an overall mortality rate of about 30% 
(102). Because the liver is the only organ responsible for detoxification of glyoxylate, 
combined liver-kidney transplantation is accepted treatment for most patients with 
severe PH.  
Enteric Hyperoxaluria.  
The most common cause of acquired hyperoxaluria is enteric hyperoxaluria. 
This abnormality is associated with chronic diarrheal states, by which saponification 
of fatty acids secondary to fat malabsorption with cations such as calcium and 
magnesium, hence lower calcium oxalate complexation and high amount of free 
oxalate available for reabsorption (103). The poorly absorbed fatty acids and bile salts 
may increase colonic permeability to oxalate, further enhancing intestinal oxalate 
absorption (104),(105).  
Dehydration, hypokalemia, hypomagnesiuria, hypocitraturia, and low urine 
pH also increase the risk of calcium oxalate stone formation in patients with chronic 
diarrheal syndrome. Malabsorption can lead to increased oxalate absorption intestines. 
Therefore small bowel resection, intrinsic disease, and jejunoileal bypass (106) have all 
been associated with hyperoxaluria.  
Prospective (107)(108) studies have shown increased urinary oxalate excretion in 
non–stone-forming individuals after Roux-en-Y gastric bypass and other 
malabsorptive bariatric procedures. The rise in urinary oxalate was shown to develop 
at least 6 months after bypass surgery (109).  
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Dietary Hyperoxaluria. Overindulgence in oxalate enriched foods such like 
potatoes, spinach, chocolate, beets, brewed tea, and nuts, can result in hyperoxaluria 
in otherwise normal people. The contribution of dietary oxalate to urinary oxalate 
excretion can range from 24% to 42% (72). In addition, severe calcium restriction may 
result in reduced intestinal binding of oxalate and increased intestinal oxalate 
absorption. Ascorbic acid supplementation has been shown to increase urinary oxalate 
levels by in vivo conversion to oxalate (110), although increased clinical rates of stone 
formation have not been unequivocally linked to ascorbic acid use (111,112).  
Cystic fibrosis patients, many of whom are exposed to prolonged antibiotic 
use, have also been shown to have absence of O. formigenes from the intestinal tract 
and corresponding elevated urinary oxalate levels (113).  
Idiopathic Hyperoxaluria. Studies quote that mild hyperoxaluria is as 
important a contributor as hypercalciuria in the pathogenesis of idiopathic calcium 
oxalate stones(79)(114) 
.Abnormalities in the metabolism and transport of oxalate may contribute to 
calcium oxalate nephrolithiasis. 
(115)By baggio and colleagues a higher rate of oxalate flux across the red blood 
cell membrane at steady state in 114 patients with a history of calcium oxalate kidney 
stones compared with control subjects. Treatment with oral hydrochlorothiazide (50 
mg/day), amiloride (5 mg/day), or both restored normal or nearly normal red blood 
cell oxalate exchange in all of the patients who initially demonstrated increased rates.  
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Hyperuricosuria  
Hyperuricosuria definition states to a more than 600mg/day excretion of 
urinary uric acid. Up to 10% of people have high urinary uric acid level who forms 
calcium stone as an isolated abnormality, but it is found along with other metabolic 
abnormalities in up to 40% of calcium stone formers (116).  
Hyperuricosuria has been postulated to increase urinary levels of monosodium 
urate, which promotes calcium oxalate crystalization in turn through varied 
nucleation, or epitaxial crystal growth (117).  
The most common cause of hyperuricosuria is increased dietary purine intake. 
However, acquired and hereditary diseases may also be accompanied by 
hyperuricosuria, including gout, myelopro- liferative and lymphoproliferative 
disorders, multiple myeloma, secondary polycythemia, pernicious anemia, hemolytic 
disorders, hemoglobinopathies and thalassemia, complete or partial HGPRT 
deficiency, overactivity of phosphoribosylpyrophosphate synthetase, and hereditary 
renal hypouricemia (118).  
Hypocitraturia  
Hypocitraturia is an important and correctable abnormality associated with 
renal calculi which exists as an isolated abnormality in up to 10% of calcium stone 
formers and 20% to 60% of stone formers with other abnormalities(119,(120). Citrate is 
an important inhibitor that can reduce calcium stone formation by several 
mechanisms. First, citrate reduces urinary saturation of calcium salts by complexing 
with calcium (37). Second, citrate directly prevents spontaneous nucleation of calcium 
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oxalate (121). Third, citrate inhibits agglomeration and sedimentation of calcium 
oxalate crystals (39)(122,123), as well as the growth of calcium oxalate and calcium 
phosphate crystals (36).  
Hypocitraturia is defined as a urinary citrate level lower than 320 mg/day. 
Acid-base state is the primary determinant of urinary citrate excretion. Metabolic 
acidosis lowers the urinary citrate levels because of mangified renal tubular 
reabsorption and low synthesis of citrate in peritubular cells (124) 
Low Urine pH  
At low urine pH (>5.5), the undissociated form of uric acid predominates, 
causing formation of uric acid and/or calcium stone. Calcium oxalate stones form as a 
result of divergent nucleation (125)(126). Any disorder leading to low urine pH may 
predispose to stone formation.  
Renal Tubular Acidosis  
RTA is a clinical syndrome is noted by metabolic acidosis secondary to 
defects in renal tubular bicarbonate reabsorption or hydrogen ion secretion. There are 
three types of RTA: which are 1, 2, and 4. Type 1 (distal) RTA is of significance to 
uro surgeons not only because it is the frequent form of RTA but also because it is 
that form of RTA where stone formation is mostly seen, which occurs in up about 
70% of affected individuals. Indeed, symptoms associated with nephrolithiasis led to 
the initial diagnosis of RTA in upward of 50% of cases(127).  
Type 1 (Distal) Renal Tubular Acidosis. Type 1 RTA includes abnormal 
collecting duct function marked by inability to acidify the urine in the presence of 
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systemic acidosis. The classic findings are hyperchloremic, hypokalemic,non–anion 
gap metabolic acidosis along with elevated urine pH (<6.0), nephrocalcinosis, and 
nephrolithiasis. 
Uric Acid Stones  
Urine pH is a deciding factor in making up of uric acid solubility;  
The three main determinants of uric acid stone formation are hyperuricosuria , 
low urine volume, and low pH. The most important pathogenetic factor is low urine 
pH because  
 
Fig 14: pathophysiology and etiology of uric acid nephrolithiasis. Three major 
pathophysiologic mechanism are low urinary pH low urine volume, 
hyperuricosuria. 
Most patients with uric acid stones have normal uric acid excretion but 
invariably demonstrate persistent low urine pH (128)(129). Uric acid stones can develop 
as a result of congenital, acquired, or idiopathic causes. Congenital dis- orders 
associated with uric acid stones involve renal tubular urate transport or uric acid 
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metabolism, leading to hyperuricosuria. Acquired causes of uric acid stones such as 
chronic diarrhea, volume depletion, myeloproliferative disorders, high animal protein 
intake, and uricosuric drugs may affect any of the three factors determining uric acid 
stone formation. Patients with “gouty diathesis” or idiopathic uric acid nephrolithiasis 
typically demonstrate decreased fractional excretion of urate and do not have gout(130). 
Patients with idiopathic uric acid nephrolithiasis differ from those with 
hyperuricosuric calcium nephrolithiasis in that the former generally have normal 
urinary uric acid levels and acidic urine, whereas the latter have hyperuricosuria and 
normal urine pH (131). Patients with hyperuricosuria frequently have high urinary 
sodium and calcium levels leading to increased urinary saturation of sodium urate and 
calcium oxalate, placing them at risk for calcium oxalate stones (132)  
Hyperuricosuria  
Hyperuricosuria is defined as urinary uric acid exceeding 600 mg/ day. 
Hyperuricosuria results in uric acid stone formation due to supersaturation of the urine 
in relation to undissociated uric acid which is sparingly soluble. Patients with gout 
and urinary uric acid levels less than 600 mg/day had significantly fewer stones than 
those with uric acid levels greater than 1000 mg/day (133)(134)  
Cystine Stones  
Cystinuria is an inherited autosomal recessive disorder (or rarely autosomal 
dominant with incomplete penetrance) marked by a flaw in intestinal and renal tubular 
transport of dibasic amino acids, causing excessive excretion of cystine in 
urine(135)(136)  
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Cysteine is more soluble than Cystine and is responsible for cystine stone 
formation.  
Several factors determine the solubility of cystine, including pH, cystine 
concentration, urinary macromolecules, and ionic strength. supersaturation is the main 
contributor to cystine crystallization because there is no specific urinary inhibitor of 
cystine crystallization(137). Because of the poor solubility of cystine in urine, 
precipitation of cystine and subsequent stone formation occur at physiologic urine 
conditions (138).  
Infection Stones  
Infection stones are primarily of magnesium ammonium phosphate 
hexahydrate (MgNH4PO4 • 6H2O)in addition may also contain calcium phosphate in 
arrangement of carbonate apatite (Ca10[PO4]6 • CO3).  
Pathogenesis  
The process of urealysis induce the formation of infection stones by providing 
an alkaline urinary environment and sufficient concentrations of carbonate and 
ammonia.Infection with urease-producing bacteria is a prerequisite for the formation 
of infection stones because urease is not present in sterile human urine. A cascade of 
chemical reactions generates the conditions conducive to the formation of infection 
stones. Urinary urea, a constituent of normal urine, is first hydrolyzed to ammonia and 
carbon dioxide in the presence of bacterial urease:  
(NH2)2CO+H2O®2NH3+CO2 
The alkaline urine that forms from this reaction (pH 7.2 to 8.0)  favors the formation 
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of ammonium:  
NH3 +H2O®NH4 +OH- (pK=9.0)  
Under physiologic conditions, the alkaline urine would prevent further 
generation of ammonium. However, in the presence of urease, ammonia continues to 
be produced, further increasing urinary pH. The alkaline environment also promotes 
the hydration of carbon dioxide to carbonic acid, which then dissociates into HCO3− 
and H+. Further dissociation of HCO3− yields carbonate and another hydrogen ion:  
CO2 + H2O ® H2CO3 (pK = 4.5) H2CO3 ® H+ + HCO3- (pK = 6.3) HCO3- ®H+ 
+CO32- (pK=10.2)  
The dissociation of hydrogen phosphate under alkaline condi- tions provides 
phosphate, thereby completing the generation of constituent ions for infection stone 
formation:  
H2PO4- ® H+ + HPO42- (pK = 7.2) HPO42- ® H+ + PO43- (pK = 12.4)  
This chemical cascade, provides necessary constituents for precipitation of 
struvite stones, along with physiologic concentrations of magnesium. Along with the 
concentrations of calcium, phosphate, and carbonate components of infection stones 
are compromised as it allows precipitation of carbonate apatite and hydroxy- apatite  
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THYROID GLAND 
 
Fig 15 : thyroid embryology – early development of the median Thyroid anlage 
as a pharyngeal pouch 
Embryo 
 The thyroid gland arises as an outpouching of the primitive foregut around the 
third week of gestation. It descends from foramen cecum in front of the pharynx as a 
bilobed diverticulum. During its descent, the anlage remains connected to the foramen 
cecum via an epithelial lined tube known as the thyroglossal duct. Endoderm cells in 
the floor of the pharyngeal anlage thicken to form the medial thyroid anlage that 
descends in the neck anterior to structures that form the hyoid bone and larynx. The 
paired lateral anlages originate from the fourth branchial pouch and fuse with the 
median anlage at approximately the fifth week of gestation. Lateral anlages are 
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neuroectodermal in origin (ultimobranchial bodies) and provide the calcitonin 
producing parafollicular or C cells. At the end of the second month, the thyroid 
reaches its final position in front of the trachea; and the thyroglossal duct tissue which 
has become solid usually breaks up and disappears. Thyroid follicles are initially 
apparent by 8 weeks, and colloid formation begins by the eleventh week of gestation. 
 
Fig 16 : Blood supply and venous drainage of the thyroid gland 
Anatomy : 
The adult thyroid gland is brown in color and firm in consistency and is 
located posterior to the strap muscles. The normal thyroid gland weighs 
approximately 20 g. The thyroid lobes are located adjacent to the thyroid cartilage and 
connected in the midline by an isthmus that is located just inferior to the cricoid 
cartilage. A pyramidal lobe is present in about 50% of patients. The true capsule of 
the thyroid is a thin, densely adherent fibrous layer that sends out septa that invaginate 
into the gland, forming pseudolobules. The thyroid capsule is condensed into the 
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posterior suspensory or Berry’s ligament near the cricoid cartilage and upper tracheal 
rings.  
 
Fig 17 : Relationship of thyroid gland to the surrounding structures 
Relations : 
The thyroid lobes extend to the midthyroid cartilage superiorly and lie 
adjacent to the carotid sheaths and sternocleidomastoid muscles laterally. The strap 
muscles (sternohyoid, sternothyroid, and superior belly of the omohyoid) are located 
anteriorly and are innervated by the ansa cervicalis (ansa hypoglossi). The thyroid 
gland is enveloped by a loosely connecting fascia that is formed from the partition of 
the deep cervical fascia into anterior and posterior divisions. 
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Fig 18: Relationship of Recurrent laryngeal nerve to the inferior thyroid. 
 
Fig 19 : Relationship of the external branch of superior laryngeal nerve and 
superior thyroid artery. In type 1 the nerve crosses the artery >1 cm above the 
superior aspect of thyroid lobe. In type 2 anatomy the nerve crosses <1cm above 
the thyroid pole (2a) or below (2b) 
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Blood supply :  
Arterial : 
Ihe principal arterial blood supply of the thyroid gland comes from the paired 
superior and inferior thyroid arteries.Even when all these arteries are ligated. 
Remnants of thyroid often survive from other small branches derived from laryngeal 
and trachea-esophageal arteries. 'Ihe superior thyroid artery is branch of the external 
carotid artery and reach the superior pole of the thyroid gland. 'Ihe inferior thyroid 
artery usually arises from the thyrocervical trunk runs superiorly behind the carotid 
artery, and then arches medially to the thyroid gland. coursing either perpendicular to 
or in a recurrent path to the thyroid gland. The thyroidea ima artery is another 
 
Fig 20 : Thyroid gland from behind artery which comes directly from the aorta. 
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Venous : The venous drainage of the thyroid gland occurs via three sets of 
veins—the superior, middle, and inferior thyroid veins. The superior and middle veins 
drain directly into the internal jugular veins. The inferior veins often drains into the 
brachiocephalic veins.  
Nerve: The left RLN arises from the vagus nerve where it crosses the aortic 
arch ascends medially in the neck within the tracheoesophageal groove. The right 
RLN arises from the vagus at its crossing with the right subclavian artery. The nerve 
usually passes posterior to the artery before ascending in the neck, its course being 
more oblique than the left RLN. Along their course in the neck, the RLNs may 
branch, and pass anterior, posterior, or interdigitate with branches of the inferior 
thyroid artery. Identification of the nerves or their branches often necessitates 
mobilization the tubercle of Zuckerkandl, at the level of the cricoid cartilage. The last 
segments of the nerves often course below the tubercle and are closely approximated 
to the ligament of Berry. The RLNs terminate by entering the larynx posterior to the 
cricothyroid muscle.  
Lymphatic System. The thyroid gland is endowed with an extensive network 
of lymphatics. Regional lymph nodes include pretracheal, paratracheal, perithyroidal, 
RLN, superior mediastinal, retropharyngeal, esophageal, and upper, middle, and 
lower jugular chain nodes.  
The second group of thyroid secretory cells is the C cells or parafollicular 
cells, which contain and secrete the hormone calcitonin. They are found as individual 
cells or clumped in small groups in the interfollicular stroma and located in the upper 
poles of the thyroid lobes.  
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Thyroid Physiology 
Iodine Metabolism. The average daily iodine requirement is 0.1 mg, which can 
be derived from foods such as fish, milk, and eggs or as additives in bread or salt. In 
the stomach and jejunum, iodine is rapidly converted to iodide and absorbed into the 
bloodstream, and from there it is distributed uniformly throughout the extracellular 
space. Iodide is actively transported into the thyroid follicular cells by an adenosine 
triphosphate (ATP)–dependent process. The thyroid is the storage site of >90% of the 
body’s iodine content and accounts for one third of the plasma iodine loss. The 
remaining plasma iodine is cleared via renal excretion. The hormones tri-
iodothyronine (T3) and l-thyroxine (T4) are bound to thyroglobulin within the colloid  
 When hormones are required, the complex is resorbed into the cell and 
thyroglobulin is broken down. T3 and T4 are liberated and enter the blood, where they 
are bound to serum proteins: albumin, thyroxine-binding globulin (TBG) and 
thyroxine-binding prealbumin (TBPA). The metabolic effects of the thyroid hormones 
are due to unbound free T4 and T3. T3 is the more important physiological hormone 
and is also produced in the periphery by conversion from T4.  
Thyroid Hormone Synthesis, Secretion, and Transport.  
The synthesis of thyroid hormone consists of several steps. The first, iodide 
trapping, involves active (ATP- dependent) transport of iodide across the basement 
membrane of the thyrocyte via an intrinsic membrane protein, the sodium/ iodine 
(Na+/I–) symporter. Thyroglobulin (Tg) is a large (660 kDa) glycoprotein, which is 
present in thyroid follicles. The second step in thyroid hormone synthesis involves 
oxidation of iodide to iodine and iodination of tyrosine residues on Tg, to form 
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monoiodotyrosines (MIT) and diiodotyrosines (DIT) which are catalyzed by thyroid 
peroxidase (TPO). A recently identified protein, pendrin, is thought to mediate iodine 
efflux at the apical membrane. The third step leads to coupling of two DIT molecules 
to form tetra-iodothyronine or thyroxine (T4), and one DIT molecule with one MIT 
molecule to form triiodothyronine (T3).. In the fourth step, Tg is hydrolyzed to release 
free iodothyronines (T3 and T4) and mono- and diiodotyrosines. Most of the T3 is 
produced by peripheral deiodination (removal of 5¢-iodine from the outer ring) of T4 
in the liver, muscles, kidney, and anterior pituitary, a reaction that is catalyzed by 5¢-
mono-deiodinase. The secretion of thyroid hormone is controlled by the 
hypothalamic-pituitary-thyroid axis.  
The thyroid gland also is capable of autoregulation, which allows it to modify 
its function independent of TSH. As an adaptation to low iodide intake, the gland 
preferentially synthesizes T3 rather than T4, thereby increasing the efficiency of 
secreted hormone. In situations of iodine excess, iodide transport, peroxide 
generation, and synthesis and secretion of thyroid hormones are inhibited. Excessively 
large doses of iodide may lead to initial increased organification, followed by 
suppression, a phenomenon called the Wolff-Chaikoff effect.  
Thyroid Hormone Function. Thyroid hormones affect almost every system in 
the body. They are important for fetal brain development and skeletal maturation. T3 
increases oxygen consumption, basal metabolic rate, and heat. It also has positive 
inotropic and chronotropic effects on the heart by increasing transcription of the Ca2+ 
ATPase in the sarcoplasmic reticulum and increasing levels of b-adrenergic receptors 
and concentration of G proteins. Myocardial a receptors are decreased, and actions of 
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catecholamines are amplified. Thyroid hormones are responsible for maintaining the 
normal hypoxic and hypercapnic drive in the respiratory center of the brain. They also 
increase gastrointestinal (GI) motility, leading to diarrhea in hyperthyroidism and 
constipation in hypothyroid- ism. Thyroid hormones also increase bone and protein 
turnover and the speed of muscle contraction and relaxation. They also increase 
glycogenolysis, hepatic gluconeogenesis, intestinal glucose absorption, and 
cholesterol synthesis and degradation.  
PARATHYROID  
Embryology  
In humans, the superior parathyroid glands are derived from the fourth 
branchial pouch, which also gives rise to the thyroid gland. The third branchial 
pouches give rise to the inferior parathyroid glands and the thymus. The parathyroids 
remain closely associated with their respective branchial pouch derivatives. The 
position of normal superior parathyroid glands is more consistent, with 80% of these 
glands being found near the posterior aspect of the upper and middle thyroid lobes, at 
the level of the cricoid cartilage.51 As the embryo matures, the thymus and inferior 
parathyroids migrate together caudally in the neck. The most common location for 
inferior glands is within a distance of 1 cm from a point centered where the inferior 
thyroid artery and RLN cross.  
Anatomy and Histology  
Most patients have four parathyroid glands. The superior glands usually are 
dorsal to the RLN at the level of the cricoid cartilage, whereas the inferior parathyroid 
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glands are located ventral to the nerve. They are often embedded in and sometimes 
difficult to discern from surrounding fat. Normal parathyroid glands are located in 
loose tissue or fat and are ovoid. They measure up to 7 mm in size and weigh 
approximately 40 to 50 mg each. Parathyroid glands usually derive their blood supply 
from branches of the inferior thyroid artery, although branches from the superior 
thyroid artery supply at least 20% of upper glands. The parathyroid glands drain 
ipsilaterally by the superior, middle, and inferior thyroid veins.  
Histologically, parathyroid glands are composed of chief cells and oxyphil 
cells arranged in trabeculae, within a stroma composed primarily of adipose cells. The 
parathyroid glands of infants and children are composed mainly of chief cells, which 
produce parathyroid hormone (PTH). Acidophilic, mitochondria-rich oxyphil cells are 
derived from chief cells, can be seen around puberty, and increase in numbers in 
adulthood. A third group of cells, known as water-clear cells, also are derived from 
chief cells, are present in small numbers, and are rich in glycogen. Although most 
oxyphil and water-clear cells retain the ability to secrete PTH, their functional 
significance is not known.  
Parathyroid Physiology and Calcium Homeostasis  
Calcium is the most abundant cation in human beings and has several crucial 
functions. Extracellular calcium is important for excitation contraction coupling in 
muscle tissues, synaptic transmission in the nervous system, coagulation, and 
secretion of other hormones. Intracellular calcium is an important second messenger 
regulating cell division, motility, membrane trafficking, and secretion. Calcium is 
absorbed from the small intestine in its inorganic form. Extracellular calcium (900 
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mg) accounts for only 1% of the body’s calcium stores, the majority of which is 
sequestered in the skeletal system. Approximately 50% of the serum calcium is in the 
ionized form, which is the active component. The remainder is bound to albumin 
(40%) and organic anions such as phosphate and citrate (10%). The total serum 
calcium levels range from 8.5 to 10.5 mg/dL (2.1 to 2.6 mmol/L), and ion- ized 
calcium levels range from 4.4 to 5.2 mg/dL (1.1 to 1.3 mmol/L). The total serum 
calcium level must always be considered in its relationship to plasma protein levels, 
especially serum albumin.  
Parathyroid Hormone.  
The parathyroid cells rely on a G-protein–coupled membrane receptor, 
designated the calcium- sensing receptor (CASR), to regulate PTH secretion by 
sensing  extracellular calcium levels . PTH secretion also is stimulated by low levels 
of 1,25-dihydroxy vitamin D, catecholamines, and hypomagnesemia. The PTH gene 
is located on chromosome 11. PTH is synthesized in the parathyroid gland as a 
precursor hormone preproPTH, which is cleaved first to pro-PTH and then to the final 
84-amino-acid PTH. Secreted PTH has a half-life of 2 to 4 minutes. In the liver, PTH 
is metabolized into the active N-terminal component and the relatively inactive C-
terminal fraction. The C-terminal component is excreted by the kidneys and 
accumulates in chronic renal failure.  
PTH functions to regulate calcium levels via its actions on three target organs, 
the bone, kidney, and gut. PTH increases the resorption of bone by stimulating 
osteoclasts and promotes the release of calcium and phosphate into the circulation. At 
the kidney, calcium is primarily absorbed in concert with sodium in the proximal 
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convoluted tubule, but fine adjustments occur more distally. PTH acts to limit calcium 
excretion at the distal convoluted tubule via an active transport mechanism. PTH also 
inhibits phosphate reabsorption (at the proximal convoluted tubule) and bicarbonate 
reabsorption. It also inhibits the Na+/H+ antiporter, which results in a mild metabolic 
acidosis in hyper- parathyroid states. PTH and hypophosphatemia also enhance 1-
hydroxylation of 25-hydroxyvitamin D, which is responsible for its indirect effect of 
increasing intestinal calcium absorption.  
Calcitonin. Calcitonin is produced by thyroid C cells and functions as an 
antihypercalcemic hormone by inhibiting osteoclast- mediated bone resorption. 
Calcitonin production is stimulated by calcium and pentagastrin and also by 
catecholamines, cholecystokinin, and glucagon. When administered intravenously to 
experimental animals, it produces hypocalcemia. At the kidney, calcitonin increases 
phosphate excretion by inhibiting its reabsorption. Calcitonin plays a minimal, if any, 
role in the regula- tion of calcium levels in humans. However, it is very useful as a 
marker of MTC and in treating acute hypercalcemic crisis. Vitamin D. Vitamin D 
refers to vitamin D2 and vitamin D3, both of which are produced by photolysis of 
naturally occurring sterol precursors. Vitamin D2 is available commercially in 
pharmaceutical preparations, whereas vitamin D3 is the most important physiologic 
compound and is produced from 7-dehydrocholesterol, which is found in the skin. 
Vitamin D is metabolized in the liver to its primary circulating form, 25-
hydroxyvitamin D. Further hydroxylation in the kidney results in 1,25-dihydroxy 
vitamin D, which is the most metabolically active form of vitamin D. Vitamin D 
stimulates the absorption of calcium and phosphate from the gut and the resorption of 
calcium from the bone.  
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In 1973 Thompson R et al, did a study to distinguish the surface contamination 
from bacteria harbouring within the stone by using a method to culture the Urinary 
calculi. Culture results were matched with the stone analysis results. struvite stones 
formed the majority, mostly resulting in recurrent infection with a urea-splitting 
bacteria, for example Proteus mirabilis. Most oxalate stones were found to be sterile. 
Occasionally relapsing urinary infection was seen due to an infected oxalate 
stone.(139) 
In 1978 Robertson WG,et al, did a study to find out the main risk factors 
involved in stone forming are shown to be calcium, oxalate, pH, acid 
mucopolysaccharides and uric acid. A route for calculating and combining the individual 
risk factors into a measure of the "relative probability" of forming stones (PSF). In stone 
formers PSF values are generally higher than in normal subjects. PSF values are lower in 
children and females than in males when comparing normal patients. Highest PSF values are 
seen in recurrent PSF and these match well with the severity of the diseases as stated by the 
no of times a stone in formed in patient.(140) 
In 1978 FREDRICL.C et al, did a study to conclude that there is a new 
syndrome evolving gradually called as hypoeruricosuric calcium oxalate kidney 
stones. it has absence of any properly defined causes of calcium stones as, 
hypercalciuric state, hyperparathyroid, hyperoxaluria and medullary sponge disease, 
but it contained ca.oxalate stones hyperuricosuria. Seen commonly in men due to 
combination of excess dietary purine and overproduction of endogenous uric acid. 4th 
and 5th decade is mostly prominent is stone formation. There is no known mechanism 
which may link hyperuricosuria to production of ca oxalate; but nucleation of 
ca.oxalate crystals by sodium hydrogen urate or uric acid in calyces or at open ends of 
Review of Literature 
 
  59 
 
renal collecting duct is one theory which is supported based on evidence.(141) 
Pakcy et al did a study In 1985 showing in cases of uric acid stone high 
urinary concentration of undissociated uric acid and a low urinary pH play an 
important role, and excess amount of supersaturation of struvite in urine and high 
urinary pH in cases of infectious stones.Absorptive hypercalciuria and hypocitraturia 
treatment patient in a patient with potassium citrate & thiazide may well be shown to 
minimise risks (hypocitraturia, relative supersaturation of calcium oxalate and 
hypercalciuria) which were evident before treatment.(142) 
Bratell s1 et al, in 1990 did a study where more than half of patient having 
UTI had surgery for renal stone extraction in a group. containing magnesium 
ammonium phosphate where seen in a significant number of the patients having 
stones which were infected, there was no growth of urease-producing enzyme on 
culture.From the samples of these patients there was significant growth of E.coli on 
the other hand. Suggesting that there is a possibility that E. coli has a role in formation 
of stone.(143) 
In 1993 Baker PW et al, did this study demonstrating the significance in uric 
acid and infection stones formation with seasonal variation. woMen are at a lower risk 
of forming stones than men, infection stones being an exception. Along with that, 
women may have distinct periods of higher risk in calcium oxalate stones,. This study 
confirms that the most common stone type are calcium oxalate stones, according to 
the studies from other industrialised countries.(144) 
In 1993 Gary C et al, concluded in his study that the risk of kidney stones was 
inversely proportional with dietary calcium intake after adjusting age; the relative risk 
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of urolithiasis for males in the peak as compared with the lowest quintile group for 
calcium intake was 0.56 (95 percent confidence interval, 0.43 to 0.73; P for trend, 
<0.001). This reduction in risk lowered only slightly (relative risk, 0.66; 95 percent 
confidence interval, 0.49 to 0.90) after further adjustment including consumption of 
alcohol and animal protein intake, potassium, and fluid which are other potential risk 
factors,. Intake of animal protein was directly associated with the risk of stone 
formation (relative risk for men with the highest intake as compared with those with 
the lowest, 1.33; 95 percent confidence interval, 1.00 to 1.77); potassium intake 
(relative risk, 0.49; 95 percent confidence interval, 0.35 to 0.68) and fluid intake 
(relative risk, 0.71; 95 percent confidence interval, 0.52 to 0.97) were inversely 
related to the risk of kidney stones. A high dietary calcium intake decreases the risk of 
symptomatic kidney stones.(145) 
Daudon M et al, in 1995 concluded in his study that the most frequent stone 
(86.48%) was Calcium oxalate, calcium phosphate (79.75%) and purines (18.64%). 
"Infection" stones had a low rate of occurrence. The sex ratio was similar to the type 
of stone composition and differed on basis of the main component. For example, in 
males calcium oxalate dihydrate (COD) was more frequent than females, with a sex 
ratio of 4.97 versus 2.57 for calcium oxalate monohydrate (COM). On the contrary in 
female patients, calcium phosphate was more frequent(sex ratio 0.72 versus overall 
ratio).(146) 
In 1996 Wisinger J et al, did a study and found 17 showed presence of 
hypercalciuria while 12 had normal urinary calcium excretion out of 29 patients with 
kidney stone, persistently elevated urinary calcium excretion were seen in all patients 
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with fasting hypercalciuria. whereas, all but one patient with absorptive hypercalciuria 
post 1 week on low calcium diet had reduced their urinary calcium excretion 
significantly.(147) 
In 2001 Gupta K et al, did a study To find the resistance of antimicrobials 
among pathogens resulting in worldwide UTI in women. After performing a survey of 
antimicrobials susceptibility from 103,223 isolates obtained from urine samples in 
1998 of female in OPD nationally and within 9 regions of the States. there was a 
resistance to trimethoprim-sulfamethoxazole in treatment of E.coli.States in Northeast 
(P<.001) a low of around 10%.(148) 
In 2001 Seema Goleccha et al, did a study which showed there was an 
increased incidence of mixed stone made up of calcium oxalate and calcium 
phosphate (51 %)revealed on Chemical analysis. Only 13% were pure triple 
phosphate stone. From pre-op urine (32.35%) and stone culture (21.73%) commonest 
pathogens were E.coli second was Pseudomonas which was from mixed stones of 
ca.oxalate with phosphate and triple phosphate. 13 out 31 had the maximum number 
of infection (84.62%) which were triple phosphate stones.(149) 
In 2001 Kourambas J et al, did a study on Patients and found to have a 
metabolic analysis showing definite metabolic disorders with non-calcium stones. 
Alternatively, patients with regard to metabolic disorders calcium stones were 
heterogeneous, but in those patients with calcium phosphate calculi there was an 
association of renal tubular acidosis. based on these reports, a simple metabolic 
evaluation and nonselective medical therapy based on the composition of the stone 
was made to facilitate assessment, treatment, and monitoring of stone disease.(150) 
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In 2002 dimkovic N et al did a study which showing the results of a chemical 
analysis of stone was available in 25 patients:In 17 patient calcium-oxalate was found, 
in 7 patients there was calcium-oxalate-magnesium-phosphate and in one patient it 
was calcium- phosphate and urate. 
 Biochemical data. Biochemical data (mean, range and number of patients 
with values out of range) the serum iPTH value of all patients were raised above the 
upper limit from 3% to 134%. In 28 patient Single iPTH test was performed and in 12 
patients analysis was repeated; a value above normal was confirmed in 7 patients. 
There were no differences between iPTH values between genders.(151) 
In 2004 Parmer M.S, et. al, did a study to showing the development of stones 
and the various causes and risk factors associated with it. The types and classification 
of stones were also mentioned in this study.(152) 
In 2005 S. Corbetta et al did a study and concluded the biochemical 
characteristics of stone former(sf) and non stone former(nsf), while serum phosphate 
and tubular maximal reabsorption of phosphate were higher in nsf than sf , nsf 
showed plasma ionised calcium, serum total calcium and nth level significantly lower 
than sf patients.(153) 
Manges A, et al, In 2006 did a study to show that there is a potential to alter 
the prevalence of resistant UTI in a community caused by E.coli clonal groups over 
time. Due to a small number of E. coli clonal groups there is a prevalence of drug-
resistant UTI in a community. This shows the usage of the type of treatment given for 
UTI in a given community. There could be a rapid alteration in the prevalence of 
drug-resistant UTI in that community if a new drug-resistance phenotype is suddenly 
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introduced . There should be implementation about the cost effective Strategies to 
view the sensitivity and resistance of UTI in a community.(154) 
In 2006 Qaader D et al stated from their study of Prevalence and etiology of 
urinary stones in hospitalized patients in Baghdad that Struvite and apatite are often 
seen along with UTI more so with urease splitting bacteria. Main cause of infection 
stones are bacterial urease enzyme. In Iraq, also there was similar reports of isolating 
bacteria from infectious stones and non-infectious stones. the urinary infection with 
urease producing bacteria is the main reason in formation of struvite stones. It is said 
that the stone formation is caused due hydrolysis of urea by urease enzyme leading to 
an ammoniacal urine, and an alkaline nature overall.Also by increasing the adherence 
of crystals bacterial infection may result in formation of stone. It was demonstrated 
that the glycosaminoglycan layer which covers the bladder mucosa is destroyed by the 
ammonium enabling the bacteria to attach to the surface of mucosa. The renal 
collecting system has a glycosaminoglycan layer which is similarly destroyed by 
bacterial infection, resulting in attachment of bacteria, inflammation of tissue, and a 
organic matrix, crystal matrix interaction is produced.(155) 
In 2008 corrado v. et al did a study and concluded primary or secondary 
disease in stone-forming patients are due complex derangements of physiological 
bone turnover documented with high serum calcium levels.(156) 
In 2010 Durgawale P. et al did a study the to gather the chemical composition 
from assessed cases of kidney stones in Karad city and adjacent areas of south west 
region of Maharashtra And document Struvite infection stones more predominant, this 
study suggested that there was precipitation of phosphates due to alkaline urine seen 
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after episodes of UTI.(157) 
In 2011 Ho ch et al did a study to conclude that compared to healthy controls 
there is more LUTS and lower urinary peak flow rates in hyperthyroid women.Only 
18.5% have moderate-to-severe LUTS and in majority is only mild (IPSS <8). Both 
LUTS and after the treatment for hyperthyroidism there was an improvement in the 
flow rates. To end, since time unknown the association of putrefying urine and stone 
has been known. Urease which is a bacterial enzyme is the primary reason for 
formation of calculus based on accumulated data obtained from clinical and all 
experiments.(158) 
In 2011 wierderkehr M stated from his study that renal manifestation of a 
systemic metabolic disorder is Uric acid stones. Low pH in urine, causing insoluble 
uric acid to precipitate is the primary cause for uric acid stones. Factors such as 
hyperuricosuria and low urine volume are lesser in deciding uric acid stone formation. 
The urine pH is quite low due to increased production in acid and the relative inability 
to act on a acid load with a compensatory increase in urinary buffers in Stone formers. 
The primary group of uric acid stone formers are those with an associated metabolic 
syndrome and conditions like primary gout or idiopathic uric acid stones, git or 
neoplastic disorders are less common causes.(159) 
In 2011, Eshwarappa M et al did a study to conclude that in diagnosing UTI, 
clinical presentation plays a small role. The most important risk factors for UTI are 
Diabetes and instruments used in Urological condition. The most widespread 
organism causing UTI in the community is still E. coli, only the presence of resistant 
ESBL species at such a high rate is a real concern. This pattern of ESBL species, is 
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ever increasing since there is an uncontrolled misuse of antibiotics that are available. 
(160) 
In 2011 Ejrnæs K et al did a study on the Bacterial characteristics of 
importance for recurrent urinary tract infections caused by Escherichia coli and 
concluded that the theory of an intracellular storage of E. coli in bladder validates the 
results. Due to the presence of pathogenic E.Coli inspite of various treatment 
challenges our present treatment module of UTI and argues for a change in the way it 
is treated by developing newer antimicrobials. There was not a particular virulence 
profile that could predict UTI. Although, the potential targets for prevention and 
treatment of UTI are VFGs associated with persistence or recurrence. Again to choose 
a more differentiated and optimal treatment we recognised potential markers. To 
develop new diagnostic tools, regimens and drugs for preventing and treating RUTI 
we need to elucidate the collection and mode of VFGs.(161) 
in 2014 Mathew d Sorensen et al did a study to find out that for cellular 
function Calcium is a vital mineral constituent. We do not completely understand 
Calcium homeostasis which is a complicated process.There may be primary or 
secondary changes in intestinal calcium absorption due to dysregulation of calcium 
homeostasis. Again, there may be an abnormal calcium absorption from the intestine 
either due to an inherent predisposition, or due to differences in calcium intake in 
patients with a history of renal calculi formation. There is first grade evidence that a 
protective factor against stone formation is dietary calcium intake . Restriction of 
dietary calcium is not advised as it may lead to higher calculus formation potentially 
through bone demineralization due to increased absorption of oxalate.(162) 
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Zhang He In 2017 Zhang He et al did a study on Relative fraction of urinary 
stone components determined using FT-IR. gathered that mixed stones percentage 
was almost 87.5% of the 120 fragments of the 40 stone in total. The predominant 
component found was CaOx monohydrate, followed by CaOx dihydrate and 
carbapatite(25%). pure UA stones were around remaining 12.5%. 
A total of 25 stones were primarily composed of CaOx. the primary part in centre, 
outer core and periphery was CaOx, excluding 7 cases in where cores were 
constituted of CaP.  Again, CaP was predominant in the inner part, while CaOx was 
found to be plenty in the periphery of CaOx stones. There was a single stone contain 
30% magnesium ammonium phosphate (struvite) in core layers.(163) 
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MATERIALS AND METHODS 
a. Study design : CROSS SECTION 
b. Study setting (exact places where the study is conducted): 
 Patients with complicated varicose veins attending General Surgery OPD 
AND IPD of Sree Mookambika Institute of Medical Sciences, Kulasekharam. 
c. Approximate total duration of the study: 18 months 
d. Number of the groups to be studied: 1 
e. Detailed description of the groups: N/A 
Sampling : 
a. Sample size of each group: N/A 
b. Total sample size used in the body: 46 
c. Scientific basis of sample size used in the study: 
ሺ1.96ሻ²࢖ࢗ
ࢊଶ  
Where p = percentage of parathyroid related renal calculi = 67.4 
q = 100-p = 100-67.4= 32.6 
d = 20% of p = 13.48 
 Therefore ଷ.଼ସ௣௤ௗమ  = 
ଷ.଼ସ௑଺଻.ସ௑ଷଶ.଺
ଵଷ.ସ଼௑ଵଷ.ସ଼  = 46.43 ≅ 46 
d. Inclusion criteria:  
All renal calculi cases above the age of 18 years, attending General Surgery 
OPD of SMIMS, Kulsekharam, giving consent for work up for the study. 
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e. Exclusion criteria: 
 Complicated renal calculi cases attending General Surgery OPD of SMIMS, 
Kulasekharam,  
 not giving consent for work up for the study. 
 Pregnant women 
 Below 18 years of age. 
f. Sampling technique : CONVENIENT 
g. Whether placebo used in the study ( yes/ no) : NO 
h. Whether drugs/medical devices used in the study (yes/no) : No 
i. If research is a clinical trial: No 
j. Parameters to be studied [If quantitative data mention the units of measurement 
[MUST]:  
 SERUM CALCIUM 
 URINE CALCIUM 
 URINE PHOSPHATE 
 THYROID FUNCTION TEST  
 URINE ROUTINE  
 URINE CULTURE 
 
k. Method(s)/Technique(s)/Instrument(s)/Reagent(s)/Kit(s) etc. used to 
measure the quantitative parameters along with their manufacturing 
source details[MUST]: NIL 
PROCEDURE : 
After acceptation of the thesis by the research and ethics committee, an 
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informed consent will be obtained from all patients with renal calculi coming to the 
General Surgery OPD of SMIMS, giving consent for study. A detailed medical 
history will be taken from the patient and detailed general physical examination of the 
patient will be performed. Details like possible cause for illness, the time for it to 
develop and previous treatment taken will be analyzed and all the data will be 
compared to conclude the alternative hypothesis. 
Laboratory investigations:  
URINE ROUTINE,  
 SR. CALCIUM  
 TFT  
 Urine calcium  
 Urine Phosphate  
 Stone Analysis. 
STATISTICAL METHOD OF ANALYSIS: 
a. Significant level decided before starting of study: A “P” value of less than 0.05 
b.  (P < 0.05) is considered as significant 
c. Statistical tests to be used for data analysis: Chi Square test 
d. Software(s) to be used for the statistical analysis: Study parameters will be entered 
in MS excel and will be analyzed using SPSS Trial Version 17.0 
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RESULTS 
Age  
The distribution of age in the study population ranges from 26 to 73 years. The 
mean age of study participants was 52.78 years and a SD of 11.59 years. 
Age characteristics 
(years) 
Values 
(N=46) 
Minimum 
Maximum 
Mean 
Standard deviation 
26 
73 
52.78 
11.59 
Table 1: Distribution according to age of participants 
 
Age Group Frequency Percentage 
Less than 30 1 2.2 
30-39 4 8.7 
40-49 14 30.4 
50-59 13 28.3 
60-69 10 21.7 
70-79 4 8.7 
Total 46 100 
Table 2: Distribution according to age group of participants 
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Fig 21 : Distribution of age group in the study population 
Majority of the study population were males (60.9%). 
Gender Frequency Percentage 
Female 18 39.1 
Male 28 60.9 
Total 46 100 
Table 3 : The frequency of renal stones according to gender. 
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Fig 22: Distribution of gender in the study population 
UTI 
In the study population, 58.7% (27) have UTI. 
UTI Frequency Percentage 
No 19 41.3 
Yes 27 58.7 
Total 46 100 
Table 4 : Frequency of UTI in total patients 
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Fig 23 : Percentage of UTI in the study population 
Urine c/s Frequency Percentage 
ESBL positive e.coli 21 45.7 
No growth 19 41.3 
Proteus mirablis 6 13.0 
Total 46 100 
Table 5 : Urine c/s reports of the study population 
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Fig 24: Distribution of isolated bacteria in the study population 
Stone analysis Frequency Percentage 
Ca. Oxalate 31 67.4 
Ca. oxalate+ uric acid 1 2.2 
Ca. phosphate 9 19.6 
Ca. phosphate + ca. oxalate 2 4.3 
Uric acid 3 6.5 
Total 46 100 
Table 6 : Stone analysis results 
46% 
41% 
13% 
ESBL positive e.coli
No growth
Proteus mirablis
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Fig 25: Distribution of type of stones in the study population 
9 (19.6%) patients have Hypocalcemia and 3 (6.5%) patients have 
hypercalcemia 
Hypercalcemia / hypocalcemia Frequency Percentage 
Hypercalcemia 
Hypocalcemia 
Normal 
3 
9 
34 
6.5 
19.6 
73.9 
Table 7: Frequency of Hypercalcemia and Hypocalcemia 
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Fig 26 : Distribution of hypercalcemia / hypocalcemia in the study population 
 
Hyperthyroid / hypothyroid Frequency Percentage 
Hyperthyroid 
Hypothyroid 
Normal 
1 
2 
43 
2.2 
4.3 
93.5 
Table 8 : Frequency of Hyperthyroid and Hypothyroid 
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Fig 27 : Distribution of hyperthyroid / hypothyroid in the study population 
Serum calcium 
The distribution of serum calcium in the study population ranges from 7.5 to 
10.9 mg/dl. The mean serum calcium level of study participants was 9.33 mg/dl and a 
SD of 0.785 mg/dl. 
Serum calcium 
(mg/dl) Values 
Minimum 
Maximum 
Mean 
Standard deviation 
7.5 
10.9 
9.33 
0.785 
Table 9 : Distribution according to serum calcium level in the study population 
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Urine calcium 
The distribution of urine calcium in the study population ranges from 1 to 
15.5. The mean urine calcium level of study participants was 4.66 and a SD of 4.18. 
Urine calcium Values 
Minimum 
Maximum 
Mean 
Standard deviation 
1 
15.5 
4.66 
4.18 
Table 10 : Distribution according to urine calcium level in the study population 
Urine phosphate 
The distribution of urine phosphate in the study population ranges from 2.4 to 
71.6. The mean urine phosphate level of study participants was 21.14 and a SD of 
19.88. 
Urine phosphate Values 
Minimum 
Maximum 
Mean 
Standard deviation 
2.4 
71.6 
21.14 
19.88 
Table 11 : Distribution according to urine phosphate level in the study 
population 
 
 
Results 
 
  79 
 
TSH 
The distribution of TSH in the study population ranges from 0.23 to 9.28. The 
mean TSH of study participants was 2.92 and a SD of 1.7. 
TSH Values 
Minimum 
Maximum 
Mean 
Standard deviation 
0.23 
9.28 
2.92 
1.7 
Table 12 : Distribution according to TSH level in the study population 
Comparison of serum calcium, urine calcium, urine phosphate and TSH in males 
and females. 
Here we compared serum calcium, urine calcium, urine phosphate and TSH 
between males and females using unpaired t test and Mann-Whitney U test. It is found 
that there was no significant difference between genders according to urine calcium, 
serum calcium, and TSH (p>0.05) and there was significant difference between males 
and females according to urine phosphate (p<0.05). 
In the present study there was highly significant association between UTI and 
isolated bacteria (p<0.001). χ2 = 46 df=2 p=0.000*** 
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Isolated bacteria 
UTI 
 
Total Yes 
N (%) 
No 
N (%) 
ESBL positive 
e.coli 21(100) 0 (0) 21 
Proteus mirablis 6 (100) 0 (0) 6 
No growth 0 (0) 19 (100) 19 
Total 27 19 46 
Tables 13: Association between UTI and isolated bacteria 
In the present study there is no relationship between hormonal abnormalities 
and stones chemical composition (p>0.05). χ2 = 1.55 df=8 p=0.992 
Type of stones 
Hormonal abnormalities 
 
Total Hyperthyroid
N (%) 
Hypothyroid 
N (%) 
Normal 
N (%) 
Ca. Oxalate 1 (3.2) 2 (6.5) 28 (90.3) 31 
Ca. oxalate+ uric acid 0 (0) 0 (0) 1 (100) 1 
Ca. phosphate 0 (0) 0 (0) 9 (100) 9 
Ca. phosphate + ca. 
oxalate 0 (0) 0 (0) 2 (100) 2 
Uric acid 0 (0) 0 (0) 3 (100) 3 
Total 1 2 43 46 
Table 14 : Relationship between hormonal abnormalities and stones chemical 
composition. 
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In this study it is found that there is no significant association between UTI 
and hormonal abnormalities (p>0.05). χ2 = 2.258 df=2 p=0.323 
Hormonal 
abnormalities 
UTI 
 
Total Yes 
N (%) 
No 
N (%) 
Hyperthyroid 1 (100) 0 (0) 1 
Hypothyroid 2 (100) 0 (0) 2 
Normal 24 (55.8) 19 (44.2) 43 
Total 27 19 46 
Table 15: Relationship between UTI and hormonal abnormalities 
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DISCUSSION 
Stone formation in the urinary tract has been seen for thousands of years, but 
during the last few decades the pattern and incidence of the disease have changed 
drastically. Urinary stone aﬀects 10-12% of the population in developed countries. 
The mean lifetime risk of stone formation has been reported in the range of 5-10%. 
Recurrent stone formation is a common part of the medical care of patients with all 
types of stone disease. The incidence of Urinary stones has been increasing recently. 
With a prevalence of >10% and an expected recurrence rate of nearly 50%, stone 
disease has a serious effect on the health care system. (164) 
Urinary stones are the 3rd most common cause of urinary tract disease. They 
are superseded only by urinary tract infections and pathological conditions of the 
prostate. Out of 70 renal stone patients examined for UTI, showed (55/70), positive 
urine cultures with a ratio (78.6%) while (15/70) showed no significant growth with a 
ratio (21.4%). In the present study it was found that the age group that suffered most 
from infection and the renal stones disease among the 20-40 year-old group was 
67.1%. Similar findings were also reported by T. Ogata et al (165) who performed a 
study in which renal stones were mostly seen in 3rd and 4th decades of life. Other 
studies are done by Baker et al. (166) who found that the average age for the 
development of infection renal stones most commonly in women between the ages of 
20 and 55 years and second peak is seen, particularly in men, between 55 and 70 years 
of age.  
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In our study we found that the infection of urinary tract by E.Coli accounted 
for 71%, Klebsiella constituted for 12%, Proteus constituted for 7%. which indicates, 
persistent urinary tract infection with urea splitting bacteria may be the initial factors 
in the synthesis of infection renal stones. In metabolic stones bacterial 
superimposition may be responsible for the recurrent urinary tract infections. It shows 
association between renal stone and urinary tract infection. Similar findings were also 
reported by Madhavi et al (167) who found that the role in the synthesis of renal stones 
is due to urinary tract infection caused by certain bacteria. Infection stones are calculi 
that occur following urinary tract infections (UTIs) caused by urease-producing gram-
negative organisms. Moreover urinary tract infection with E.Coli shows the 
conversion of commensal population into pathogenic organisms this may be due to 
decreased intake of water leading to the increased concentration of urine and also 
injury caused by the peculiar characteristics of the calculi to the urinary tract  
epithelium, thus forming a nidus for growth of bacteria thus acting as a good media 
for pathogenic organisms to grow.  
INTERPRETATION AND COMPARING THE FINDINGS FOR AGE 
We conducted a study on 46 patients (chi square test), and demographic data 
according to the distribution of age the mean value was 52.78 + - 11.59. We found out 
that the maximum prevalence of renal calculi was in the age bracket of 40-49 years. 
Our study was similar to the study of martin L (168) who concluded that the average 
age of onset of urolithiasis was 38 years (range 4-73 years) and it was significant with 
less water intake, familial history of stones, recurrence in formation of stone. 
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Ahmad et al conducted a study to analyse the prevalence of renal calculi 
according to type age and gender and analysed that the highest number of cases were 
371 (31.5%) in the age group of 40-49 years. The mean age plus standard deviation of 
the patients was 41.45 ± 14.11 years for men and 39.20 ±12.21 for women. Male 
predominance was in the age group 40-49 whereas female preponderance was found 
in the age group 30-39 years. (169) 
INTERPRETATION AND COMPARING THE FINDINGS FOR GENDER 
According to a study conducted by Trinchieri A (170) to investigate the 
epidemiology of urolithiasis in western population where he concluded that Renal 
stones were usually described as more frequent in men , which was in accordance to 
out study where male prevalence was dominant over female population (60.9% in 
males over 39.1% in females)  
In a study conducted by Norlin A entitled Urolithiasis. A study of its 
frequency he stated that in a total of 986 outpatients (793 men and 193 women) there 
was an increase in incidence for upper urinary tract calculi in men from 2.2 to 3.3 (p< 
0.001) and in women from 0.5 to 0.8 (0.01 < p < 0.05) which showed results similar 
to our study. (171) 
INTERPRETATION AND COMPARING THE FINDINGS FOR URINARY 
TRACT INFECTION 
From our study we concluded that out of the 100% population 58.7% had UTI 
and 41.3% did not have UTI which was reasonably similar to the study conducted by 
Li Yongzhi et al (172) who said that the female patients had a higher rate of urinary 
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tract infection than male patients (32.0 vs 15.8%, P < 0.001) and further concluded 
that patients with obstructions were more prone to be infected than those without 
obstructions (26.1 vs 18.2%; P =0.006) and patients with multiple stones had a higher 
rate of infection than those with a single stone (41.3 vs 16.0%, P = 0.001). 
Although, there were other contradicting studies like one conducted by Kumar 
A (173). He further stated that the prevalence of Renal Stone was higher without UTI 
(44.4%) than those with UTI (27.8%) in males which was statistically significant (p < 
0.01) and in case of females the result showed (17.6%) and (5.1%) in cases with and 
without UTI where (p < 0.001) . Hence he stated that males had higher incidence of 
RS than females with a prevalence of (p < 0.0001). 
INTERPRETATION AND COMPARING THE FINDINGS FOR URINE 
CULTURE SENSITIVITY REPORT 
In a report conducted by Holmgren K (174) , he found out that patients with 
urinary tract infection (UTI), E. coli was the most frequent microorganism (35%), 
followed by Proteus (28%). After analysis stone content he stated that patients 
infected with E. coli had more phosphate containing stones (CaP+MAP) than non-
infected patients. This study was close to our study where we conclude that out of a 
study group of 46 , 21 patients had E.Coli (45.7%) infection followed by 6 patients 
with Proteus Mirablis infection (13%). While 19 patients ( 41.3%) showed no growth 
of bacteria. 
Extensive characterizations of bacteria isolated from catheterized urine and 
stone matrices in patients with nephrolithiasis. Tavichakorntrakool R1, 
Prasongwattana V, Sungkeeree S, (175) 
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Our study was yet again reasonably similar to the study conducted by 
Tavichakorntrakool R where from 100 stone formers recruited, 36 cases had a total of 
45 bacterial isolates cultivated from their catheterized urine and/or stone matrices. 
Among these 36 cases, chemical analysis by Fourier-transformed infrared 
spectroscopy revealed that 8 had the previously classified 'infection-induced stones', 
whereas the other 28 cases had the previously classified 'metabolic stones. Escherichia 
coli was the most common bacterium (approximately one-third of all bacterial 
isolates) found in urine and stone matrices (both nidus and periphery) (r = 0.860, P < 
0.001) . Multi drug resistance was frequently found in these isolated bacteria. Hence 
they concluded that microorganisms were mostly E.Coli in urine and stone matrices 
of the stone formers in Thailand. 
In an another study conducted by Kamran H et al (176) , they stated infection 
was present in 79% of cases out of which the commonest organisms isolated 
according to culture report were; 
 E. Coli (30%),  
 Proteus (19%),  
 Klebsiella (11%),  
 Pseudomonas (7%) 
 Staphylococcus aureus (3%)  
Hence , it was inferred that renal calculi makes an important group in 
urolithiasis and Synthesis of renal stones are caused by certain bacteria which are 
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cultured from urine in cases of UTI. 
The comparison of microganism showed that e.coli was predominant micro 
organism which were isolated from crushed stone and pre op urine. The present study 
thus revealed that urolithiasis is predominant in males. The mixed stones are mainly 
of calcium (oxalate and phosphate) are more common but are least in bacterial 
isolation.Micro-organisms frequently isolated from triple phosphate stones which 
were less common. So it is concludes that the microorganism can alter the formation 
of stone in different ways. To compare all the study we find that stone formation is a 
dynamic and multifactorial process. (177) 
The cases of sterile kidney stones made of calcium oxalate and calcium 
phosphate (84.31 %) was more in comparison to stones (15.69%)which were infected 
and of similar composition. By contrast triple phosphate (84.62%) had more 
infectious stones compared to triple phosphate along with calcium oxalate (61.54%). 
E. coli (32.25%) was prevalent from about one-third of stones(crushed) followed by 
Pseudomonas aeruginosa (22.58%). Staphylococcus aureus, coagulase negative 
staphylococci, Enterococcus faecalis and Klebsiella spp. were seen in less cases. Out 
of 8 calcium (oxalate & phosphate),stones, the isolation rate of Pseudomonas 
aeruginosa was 50% and in case of triple phosphate stone it was isolated in 27.27% 
cases. According to Dajani and Bratell et al. (179) (178).  
The bacteriological study of urinary samples showed that commonest 
pathogens were E.coli, Pseudomonas aeruginosa, Enterobacter spp. and Proteus spp. 
E.coli is not considered to be a stone producing micro-organism besides also not 
being a urease producing organism. However the present study showed that E.coli 
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was predominantly recovered from mixed stones (calcium oxalate, triple phosphate 
and calcium phosphate). Escherichia coli was most frequently isolated (43 strains) and 
urease-producing organisms, such as Proteus mirabilis, were cultured from 40 
patients. The core culture of 20 staghorn calculi yielded 15 isolates from 14 stones. 
There were 13 identical species isolated from the urine and stone specimens of 13 
patients (65%), including 7 strains of P. mirabilis. (180) 
INTERPRETATION AND COMPARING THE FINDINGS FOR ANALYSIS 
OF STONE 
According to chemical analysis of the stone in a study conducted by Grenabo 
L; (181) 
 66% - calcium stones 
 30% - infection stones 
 4% - uric acid/ urate stones  
 1% - cystine stones.  
10 % of the stones were staghorn calculi. 
Stone Analysis in our study concludes the following ; 
1. 67.4% - Ca oxalate 
2. 19.6 % - Ca phosphate  
3. 6.5% - Uric acid 
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4. 4.3% - Calcium phosphate + Calcium oxalate 
5. 2.2% - Uric acid + Calcium oxalate 
The before mentioned study was reasonably similar to our study. 
An epidemiological study about the composition of urinary stones in Morocco 
with respect to age and sex , African Journal of Urology, Volume 21, Issue 3, 
September 2015, Pages 194-197 M.BouatiaL.Benramdane M.Oulad Bouyahya Idrissi 
(182) 
An epidemiological study conducted to analyse the composition of urinary 
stones ,by M.Bouatial, states that the majority of stones were composed of  
I. calcium oxalate (66.6%) 
II. anhydrous uric acid (18.1%) 
III. carbapatite (7.9%) 
IV. struvite (4.4%)  
V. cystine (0.6%).  
Here we found a striking similarity between both the studies and came to a 
conclusion that most of the stone associated with infection were Calcium oxalate 
stones followed by Uric acid. 
With a reasonable similarity between our study and a study conducted by 
Golechha S (183), in where the maximum number of stones were composed of calcium 
oxalate - calcium phosphate (50%), triple phosphate (27.27%) and triple phosphate - 
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calcium oxalate (37.50%) ,we conculde that the frequency of calcium oxalate stones is 
strikingly higher in patients with renal calculi, although other composition stones 
cannot be ruled out e.g; Ca phosphate , Uric acid. 
INTERPRETATION AND COMPARING THE FINDINGS FOR THYROID 
LEVELS AND CALCIUM LEVELS IN STUDY POPULATION 
From our study, we came to a conclusion that although out of a study 
population of 46, 36 patients had normal calcium levels , 9 patients (with a frequency 
% of 19.6) had hypercalcemia whereas 3 (with a frequency % of 6.5) had 
hypocalcemia. Hence, there is possibility of patients suffering from hypercalcemia 
developing renal stones of calcium content. 
 We could not find the inter relationship between abnormal levels of thyroid 
and presence of renal stones. Our study states that out of a population of 46 , 43 had 
normal thyroid levels , and only 2 (4.3%) patients had reduced TSH levels.  
The result of crystallization was not too much different between 
hyperparathyroid patients in normal patients and those having hypercalciuria. This 
study suggests that urinary stones are not as such a result of hypercalciuria and 
promotors of calcium oxalate crystallization and calcium stone formation are seen in 
urine of hyperparathyroid patients. (184) 
RESULTS: 
It was summarised that excretion of Urinary oxalate increases as dietary 
oxalate intake increased. With diets oxalate-containing, the mean contribution of 
dietary oxalate to urinary oxalate excretion ranged from 24.4 +/- 15.5% on the 10 
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mg/2500 kcal/day diet to 41.5 +/- 9.1% on the 250 mg/2500 kcal/day diet, which was 
much more than previously estimated. When the calcium content of a diet containing 
250 mg of oxalate was reduced from 1002 mg to 391 mg, urinary oxalate excretion 
increased by a mean of 28.2 +/- 4.8%, and the mean dietary contribution increased to 
52.6 +/- 8.6%. 
CONCLUSIONS 
They suggest for urinary oxalate excretion, dietary oxalate makes a much 
greater contribution than previously recognized, and that dietary calcium influences 
the bioavailability of ingested oxalate, and that dietary oxalate absorption may be an 
important factor in calcium oxalate stone formation. (185) 
INTERPRETATION OF SERUM CALCIUM , URINE CALCIUM , URINE 
PHOSPHATE , TSH VALUES IN STUDY POPULATION  
From our conduct we could not appreciate any relationship between high 
levels of serum calcium , urine calcium , urine phosphate and thyroid hormones and 
presence of renal stones .  
INTERPRETATION OF ASSOCIATION BETWEEN UTI AND ISOLATED 
BACTERIA  
In our study there was a very highly significant association between UTI and 
isolated bacteria (with a P value < 0.001) , 21 % population affected with UTI , the 
culture sensitivity report suggested the presence of E.Coli in the urine collected from 
mid stream sample. 
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CONCLUSION 
Over all our study showed significant and positive results based on various 
aspects of Renal calculi, UTI, Thyroid, Parathyroid hormones but successful 
establishment of relationship could not be elicited 
However, our study being only of 46 patients resulted being insignificant in 
few variables. Had this study been conducted on a large scale, then positive results 
could be expected. Hence we conclude:  
The incidence of stone formers are seen mostly in the age bracket of 40-49 
years, most commonly found in males than females. 
We found a strong association between UTI and Renal stones, in which 58.7% 
suffering from renal calculi had UTI in our study. 
Among all the studies of urine culture, E.Coli was the most predominant 
organism (45.7%) associated with stones. 
Ca-Oxalate predominated our study but there was limited inter-relationship 
between Serum Calcium , Urine Calcium ,Urine Phosphate and TSH. 
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CONSENT FORM 
PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Volunteers, 
      We welcome you and thank you for your keen interest in participating in this 
research project. Before you participate in this study, it is important for you to 
understand why this research is being carried out. This form will provide you all the 
relevant details of this research. It will explain the nature, the purpose, the benefits, the 
risks, the discomfort, the precautions and the information about how this project will be 
carried out. It is important that you can read and understand the contents of the form 
carefully. This form may contain certain scientific terms and hence, if you have any 
doubts or if you want more information, you are to ask the study personnel or the contact 
person mentioned below before you give your consent and also at any time during the 
entire course of the project. 
1. Name of the Principal Investigator: Dr. Deepam Sundar Das. 
Postgraduate – M.S. General Surgery 
Sree Mookambika Institute of 
Medical Sciences 
Kulasekharam 
 
2. Name of the Guide:   Dr. Soundara Rajan 
Professor 
                                                                        Department of General Surgery 
Sree Mookambika Institute of Medical 
Sciences 
Kulasekharam 
 
3. Name of the Co-Guide:   Dr. Vinu Gopinath 
Associate Professor 
                                                                        Department of Urologyu  
Sree Mookambika Institute of Medical 
Sciences 
Kulasekharam 
 
4. Institute Address:                      Sree Mookambika Institute of Medical       
Sciences And Hospital 
Kulasekharam 
                                                                      Kanyakumari District - 629161 
                                                                      Tamil Nadu 
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5. Title of the study: TO ASSESS THE INTERRELATIONSHIP BETWEEN 
RENAL CALCULI,THYROID AND PARATHYROID HORMONES AND 
URINARY INFECTIONS AT TERTIARY CARE CENTRE 
6. Background study :                            
Renal calculi are due to accumulation of various kinds salts depositing in the 
kidneys like calcium,oxalate and phosphate. 
Urolithiasis is a common findings of urinary tract proceeded by urinary tract 
infections  and pathologic features of the prostate.a lot of factors play a role in 
this be it environment,genetics,dietary habits,urine habits,metabolic conditions 
and drugs
 
 
There is no single method of treatment appropriate for all cases. Conventional 
surgery is safe and effective and is still widely practiced. Whilst the new 
treatment methods may be popular with both surgeons and patients, it is 
important that they are carefully evaluated not only for their clinical benefits and 
complications when compared to existing treatments but also for their cost prior 
their wider acceptance into clinical practice. 
7. Aims and objectives : 
a. To study  the  relation between  thyroid and parathyroid involvement in patients 
with renal calculi 
b. To study the relation between urinary tract infection and renal calculi 
c. To study the effect of selected ions with respect to renal calculi in patients 
 
8. Scientific justification of the study : 
Stones with recurrence. As of now, surgical treatment of renal calculi is common, but 
there is limited studies based on the interrelationship between renal calculi,thyroid and 
parathyroid hormones and urinary infections remains uncertain. Very few studies have 
been conducted in India especially South India. So I intend to assess the relationship 
between renal calculi,thyroid and parathyroid hormones and urinary infections and 
preventing patient to undergo surgery and the complications pertaining to it, and also in 
understanding the risk factors leading to renal calculi. 
 
9. Procedure of the study : 
After acceptation of the thesis by the research and ethics committee, an informed 
consent will be obtained from all patients with renal calculi coming to the 
General Surgery OPD of SMIMS, giving consent for study. A detailed medical 
history will be taken from the patient and detailed general physical examination 
of the patient will be performed and the data will be analyzed accordingly. 
 
10. Expected risk of the participants: Minimal risk 
11. Expected Benefits of the Research for the participants: NIL 
12. Maintenance of confidentiality: All data collected for the study will be 
kept confidentially and would reflect on general statistical evaluation only would 
not reveal any personal details 
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13. Why have I been chosen to be in this study: You have renal calculi 
and fulfill the criteria of selection. 
14. How many people will be in the study: 46 
15. Agreement of compensation to the participants: No 
16. Anticipated prorated payment, if any, to the participants of the 
study: Nil 
17. Can I withdraw from study at any time during the study period: 
Yes 
18. If there is any new finding/information, would I be informed: Yes 
19. Expected duration of the study: 18 months (May 2017 – October 2018) 
20. Any other pertinent information: No 
21. Whom do I contact for further information: Dr. Deepam Sundar Das 
For any study related queries, you are free to contact 
Dr. Deepam Sundar Das 
Post Graduate – M.S General Surgery 
Department of General Surgery 
Sree Mookambika Institute of Medical Sciences, 
Kulasekharam 
Mobile number: 09830023980 
e-mail: drdeepam64@gmail.com 
 
 
Signature of Principal Investigator 
Place: 
 
Date:                                                                                           Signature of Participant  
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CONSENT FORM 
 
PART 2 OF 2 
PARTICIPANTS CONSENT FORM 
 
The details of the study have been explained to me in writing and details have been 
fully explained to me. I am aware that the results of the study may not be directly 
beneficial to me but will help in the advancement of medical sciences. I confirm that 
I have understood the study and had the opportunity to ask questions. I understand 
that my participation in the study is voluntary and that I am free to withdraw at any 
time, without giving any reasons, without the medical care that is normally provided 
by the hospital being affected. I agree not to restrict the use of any data or results that 
arise from this study provided such a use is only for scientific purpose(s). I have 
given details of the study. I fully consent to participate in the study titled “A 
Comparative Study to assess the interrelationship between renal calculi,thyroid and 
parathyroid hormones and urinary infections” in Sree Mookambika Institute of 
Medical Sciences, Kulasekharam. 
 
Serial no/Reference no: 
Name and Address of the participant:                                                       
Contact number of the Participant: 
 
 
                       Signature/Thumb impression of the participant/Legal guardian 
 
Witness 
       1. 
       2. 
 
Date: 
Place: 
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PROFORMA 
 
Case No. :     IP/OP No. : 
Name :      
Age : [Infant/1-14/15-45/46-60/>60] 
Sex : M/F 
Occupation : [Professional/Intermediate/Non-manual skilled/Manual skilled/Partly 
skilled/Unskilled] 
Address : 
Income : (in Rupees)[>19575/19574-9788/9787-7323/7322-4894/4893-2936/2635-980/<979] 
 
I  Chief Complaints : 
1. Pain in the abdomen 
2. Vomiting 
3. Fever 
4. Others 
II History of presenting illness : 
a) Abdominal Pain : 
i) Duration 
ii) Site 
iii) Character 
iv) Radiation 
v) Progress 
vi) Aggravating or relieving factors 
vii) Unilateral or Bilateral 
 
b) Vomiting [Yes/No] 
i) Quantity 
ii) Color 
iii) Pre meals or Post meals  
iv) Content 
 
c) Fever [Yes/No] 
i) Duration 
ii) Diurnal variation 
iii) Aggravating or relieving factors 
iv) Progress 
 
d) Swelling [Yes/No] 
i) Onset 
ii) Duration 
iii) Progress 
iv) Unilateral or Bilateral 
 
e) Hematuria [Yes/No] 
i) Quantity 
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ii) Relation to micturation [At start / Towards the end / 
Throughout] 
iii) Associated with pain 
f) Frequency of Hematuria 
i) Increased or Decreased 
ii) Nocturia 
g) Difficulty in micturation (Dysuria) [Yes/No] 
h) Retention of urine [Yes/ No] 
i) Anuria [ Yes/No] 
j) Discharge from the urethra [Yes/No] 
k) Incontinence [Yes/No] 
l)  Others 
 
III.  PAST HISTORY : 
 Type 2 Diabetes Mellitus [Yes/No] 
  Systemic Hypertension [Yes/No] 
  Tuberculosis [Yes/No] 
Abdominal tumours [Yes/No] 
Gonorrhea  
Syphilis  
Pregnancy [Yes/No] 
 
IV. TREATMENT HISTORY 
m) Conservative 
 Drink plenty of fluids 
 
 
n) Operations 
 
 
V.  FAMILY HISTORY :  
Similar complaints in family [Yes/No] 
 
VI.  PERSONAL HISTORY 
 Occupation [Duration of standing]     
 Diet 
 Appetite 
 Sleep 
 Bowel & Bladder (Constipation [Yes/No]) 
 Alcoholism [Yes/No] 
 Smoking [Yes/No]   
 Weight loss [Yes/No] 
 Pregnancy [Yes/No]   
 Menstrual history 
 
 
VII.  GENERAL PHYSICAL EXAMINATION 
Built [Weight/Height]  Nourishment 
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Pallor [Yes/No]   Icterus [Yes/No] 
Oedema [Yes/No]   Clubbing [Yes/No] 
Temperature   Cyanosis [Yes/No] 
Generalized lymphadenopathy  [Yes/No] 
Pulse  BP  Respiratory rate 
 
VIII.  LOCAL EXAMINATION : 
1. Inspection 
In recumbent postion 
- Location of swelling 
- Movement of swelling with respiration 
In sitting position 
- Fullness below the last rib  
 
2. Palpation 
Bimanual palpation 
Feel during respiration 
Reniform shape 
Ballotable swelling 
Moves on respiration 
Band of colonic resonance anteriorly 
Dull posteriorly 
Fingers can be insinuated between coastal margins and swelling 
 
IX. CLINICAL TESTS 
 Renal angle test or Murphy’s Kidney Punch Test 
 Ballottement 
 
 
XI.  SYSTEMIC EXAMINATION: 
 CVS 
 RS 
 CNS 
 Per abdomen  
Mass 
Radiating pain  
 Skeletal system    
Spine  Hip  Knee/feet 
 
XII.  INVESTIGATIONS: 
RENAL FUNCTION TESTS 
SERUM CALCIUM 
THYROID FUNCTION TESTS 
URINE ROUTINE 
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URINE CULTURE AND SENSTIVITY 
STONE ANALYSIS 
USG KUB 
 
XIII.  CLINICAL DIAGNOSIS 
 
 
∞THE END∞ 
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1 M 44 Yes ESBL 
POSITIVE 
8.1 2.2 5.1 ca. Oxalate 0.23 - Y Y -
2 M 68 Yes ESBL 
POSITIVE 
7.5 4.8 2.4 uric acid 0.67 - Y NORMAL RANGE NORMAL RANGE
3 M 70 Yes ESBL 
POSITIVE 
10.1 3.3 9.6 uric acid 0.78 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
4 F 45 Yes ESBL 
POSITIVE 
9.3 3.3 19 Ca.phos 0.89 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
5 M 72 No NO GROWTH 10.6 1.9 3.5 ca. Oxalate 0.92 Y - NORMAL RANGE NORMAL RANGE
6 F 63 Yes ESBL 
POSITIVE 
9.5 9.1 50 Ca.phos 1.1 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
7 M 55 Yes ESBL 
POSITIVE 
9.4 16 4.3 ca. Oxalate 1.23 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
8 F 38 Yes ESBL 
POSITIVE 
9.7 1.4 16 Ca.phos 1.3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
9 F 42 NO NO GROWTH 8 2 24 ca. Oxalate 1.4 - Y NORMAL RANGE NORMAL RANGE
10 M 26 No NO GROWTH 9.8 1.6 5.6 ca.oxalate 1.5 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
11 M 73 Yes ESBL 
POSITIVE 
E.COLI
8.4 1.7 4.6 ca. 
oxalate+ 
uric acid
1.54 - Y NORMAL RANGE NORMAL RANGE
12 M 51 YES PROTEUS 
MIRABLIS
9.8 1.3 10 ca.oxalate 1.6 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
13 M 53 YES PROTEUS 
MIRABLIS
8.1 1.5 29 ca.oxalate 1.8 - Y NORMAL RANGE NORMAL RANGE
14 M 40 No NO GROWTH 9 5.6 4 ca. Oxalate 1.9 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
15 M 65 No NO GROWTH 9.3 5 5.4 ca. Oxalate 1.93 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
16 M 60 YES PROTEUS 
MIRABLIS
9.7 1.9 38 ca.oxalate 2.1 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
17 M 47 Yes ESBL 
POSITIVE 
9.2 2.4 4.3 ca. Oxalate 2.13 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
18 F 62 NO NO GROWTH 8.3 2.7 70 ca. Oxalate 2.2 - Y NORMAL RANGE NORMAL RANGE
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19 M 40 No NO GROWTH 10.1 13 53 ca. Oxalate 2.44 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
20 F 55 Yes ESBL 
POSITIVE 
9.4 1.5 12 Ca.phos 2.45 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
21 M 49 Yes ESBL 
POSITIVE 
9.5 1 6.4 Ca.phos 2.5 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
22 F 35 Yes ESBL 
POSITIVE 
9.6 1.3 34 Ca.phos 2.66 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
23 F 53 NO NO GROWTH 9.9 4.2 36 ca. Oxalate 2.7 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
24 F 40 Yes ESBL 
POSITIVE 
8.2 9.9 65 Ca.phos 2.9 - Y NORMAL RANGE NORMAL RANGE
25 F 59 NO NO GROWTH 9.6 4.4 29 ca. Oxalate 3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
26 F 60 NO NO GROWTH 10 1.5 13 Ca.phos 3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
27 M 42 No NO GROWTH 9.1 1.1 4.1 ca.oxalate 3.1 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
28 F 37 NO NO GROWTH 10.1 1.9 12 ca. Oxalate 3.29 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
29 M 56 YES PROTEUS 
MIRABLIS
9.9 14 13 ca.oxalate 3.3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
30 F 66 Yes ESBL 
POSITIVE 
10.7 10 67 ca. Oxalate 3.4 Y - NORMAL RANGE NORMAL RANGE
31 M 58 NO NO GROWTH 8.6 1.3 30 ca. Oxalate 3.56 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
32 M 38 Yes ESBL 
POSITIVE 
9.3 11 41 ca.oxalate 3.56 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
33 F 59 Yes ESBL 
POSITIVE 
9 7.6 28 ca. Oxalate 3.66 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
34 F 42 Yes ESBL 
POSITIVE 
10 1.6 12 ca. Oxalate 3.87 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
35 F 67 Yes ESBL 
POSITIVE 
9.2 2.5 33 Ca.phos + 
ca oxalate
4.18 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
36 M 46 No NO GROWTH 8 3.3 5.6 ca.oxalate 4.2 - Y NORMAL RANGE NORMAL RANGE
37 M 53 No NO GROWTH 9 6.7 3.9 ca. Oxalate 4.3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
38 F 42 NO NO GROWTH 10.2 1.2 16 Ca.phos 4.3 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
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39 M 53 Yes ESBL 
POSITIVE 
9.7 12 72 ca. Oxalate 4.33 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
40 F 42 Yes ESBL 
POSITIVE 
9 1.9 5.9 Ca.phos + 
ca oxalate
4.44 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
41 M 46 No NO GROWTH 9.6 1.2 4.4 ca.oxalate 4.5 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
42 M 68 No NO GROWTH 10.9 4.5 34 uric acid 4.7 Y - NORMAL RANGE NORMAL RANGE
43 M 70 No NO GROWTH 9.3 1.6 12 ca.oxalate 5 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
44 M 66 YES PROTEUS 
MIRABLIS
9.9 6.7 10 ca.oxalate 7.2 NORMAL RANGE NORMAL RANGE - Y
45 M 56 Yes ESBL 
POSITIVE 
8 6 3.2 ca. Oxalate 1.51;0.49;9.2
8
- Y - Y
46 M 42 No NO GROWTH 9.1 1.1 4.1 ca.oxalate 3.1 NORMAL RANGE NORMAL RANGE NORMAL RANGE NORMAL RANGE
